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Despite an increasing attention received in the last decades, attention-
deficit/hyperactivity disorder (ADHD) in adults has continued to be 
understudied and underdiagnosed. Empirical researches have 
addressed most of the controversial issues and has supported the 
persistence of ADHD in adults. Epidemiological and clinical studies 
indicated that ADHD and comorbid disorders that often coexist in 
childhood continue into adulthood, leading to a medical and economic 
burden; even if the extent of the burden of ADHD is unknown, it worsens 
when the disorder and cormorbid disorders are untreated (Biederman J., 
2004). 
ADHD is characterized by a continuous history of hyperactivity, 
forgetfulness, distractibility, impulsiveness and/or inattention, starting 
from the early childhood and at a more severe extent than whatever may 
be usual in peers. Originally described in pediatric populations, it is 
widely recognized in adults. A recent 10-year follow-up study examined 
the age-dependent persistence of ADHD in young patients during the 
transition from adolescence into early adulthood. At follow-up ADHD was 
considered persistent if subjects met full or subthreshold (more than half 
of the symptoms required for a full diagnosis) DSM-IV diagnostic criteria. 
The study followed-up 110 patients with ADHD and 105 non-ADHD 
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controls. While 65% of children with ADHD no longer met full DSM-IV 
criteria for ADHD at the 10-year follow-up, 78% of subjects showed at 
least one or more relevant symptoms, or failed to attain functional 
remission (Global Assessment of Functioning, GAF score < or =60). 
Persistence of ADHD as described here was associated with higher 
rates of psychiatric co-morbidity, more family history of mood disorders 
and higher levels of educational and interpersonal impairments than 
controls (Biederman J et al., 2010).  
ADHD teenager patients are more likely to be prone to accidents like 
dog-bites and burns, and display an unhealthy lifestyle: smoking, alcohol 
and drug abuse, risky sexual lifestyle, chronic sleep problems with 
delayed falling asleep and awakening. Criminality in adulthood, 
especially when associated with substance abuse and antisocial 
personality, is predicted by ADHD and comorbid conduct disorder in 
childhood. 
While the disorder in children is mostly described as a disorder involving 
hyperactivity and impulsiveness, in adulthood ADHD inattention prevails 
on externalizing features, with a higher rate of psychiatric comorbidities, 
including major depressive disorder, bipolar disorder (BD), anxiety 
disorders and substance abuse (Klassen LJ. et al., 2010). In recent 
years, evidence has been growing regarding high levels of comorbidity 
between ADHD and other disorders, including mood and anxiety and 
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conduct disorders. Thus, ADHD diagnosis seems to comprehend 
different groups of conditions, rather than a single homogeneous clinical 
entity, with potentially different etiopathogenetic substrates and different 
outcomes. Follow-up studies of children with ADHD indicate that 
subgroups of subjects with ADHD and comorbid disorders have a poorer 
outcome as evidentiated by significantly greater social, emotional, and 
psychological difficulties (Spencer TJ, 2006). 
Wender (1998) provided a list of adult behaviours linked to childhood 
ADHD (see also Weiss & Murray, 2003; Asherson, 2005). Motor 
hyperactivity may be replaced by a subjective sense of restlessness, 
difficulty in relaxing and settling down and dysphoria when inactive. 
Attention deficits may as well persist in a lack of concentration on detail, 
the need to re-read materials several times, forgetting activities and 
appointments, losing things and losing the thread of conversations. 
Thoughts are unfocused and ‗on the go‘ all the time. Mood changes are 
represented by rapid shifts into depression or excitability, irritability and 
temper outbursts that interfere with relationships. Disorganisation is 
prominent, tasks are not completed, problem-solving strategy is lacking 
and time management is particularly poor. Enduring impulsivity leads to 
problems in teamwork, abrupt initiation and termination of relationships, 
and liability to set up quick decisions without full analysis of the situation 
(Asherson et al., 2007). 
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ADHD is estimated to affect approximately 5.29% of school-aged 
children and is therefore the most common childhood onset 
psychological disorder. A conservative estimation of the annual society 
cost of ADHD in childhood and adolescence is USD 42.5 billion in the 
U.S. Global sales of ADHD medicines could reach USD 4.3 billion by 
2012. Despite the prevalence, high heritability and costs of ADHD, 
biological markers do not exist and diagnosis is made on the basis of 
screening interviews. The individuation of biomarkers could permit an 
early and reliable diagnosis and an appropriate therapeutic approach. 
Lack of markers likely stems from several factors that complicate ADHD 
research and the assessment of pharmacological responses (Wallis D., 
2010) 
Instruments for diagnosing ADHD in childhood are well validated and 
reliable, but the diagnosis of ADHD in adults remains problematic 
(Barkley RA., 2009). Discussions about the appropriateness of DSM-IV 
criteria for adult ADHD are controversial, since they were designed for 
and based on studies on children (Davidson MA., 2008). Recent 
publications indicate that diagnosing ADHD in adulthood using DSM-IV is 
hampered if the number of symptoms does not achieve the threshold for 
diagnosis or if onset prior to the DSM-IV age at onset criterion cannot be 
established (Faraone SV., et al, 2006). Several physicians focus on 
major psychiatric diseases (major depressive disorder, bipolar disorder, 
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anxiety disorders and substance abuse) but not on ADHD (Goldstein 
2009). 
Therefore, many symptoms that are directly attributable to ADHD are 
often mistakenly associated with other psychiatric conditions and 
consequently not fully treated (Fischer et al., 2007; Kessler et al., 2006). 
Treating ADHD has been shown to decrease the severity of comorbid 
substance abuse, although in severe cases, treating substance abuse 
first might be necessary to ensure treatment compliance (Newcorn et al., 
2007). Considering the current lack of empirical data on treatment of 
ADHD and comorbidities, patients should be managed on a case-by-
case basis, with the most severe condition given treatment priority. 
The comorbid presentation of people suffering from ADHD and BD 
(ADHD/BD) is associated with a more severe disease course, more 
severe mood disorder symptoms, and lower functional scores. 
Importantly, the co-segregation of these two conditions makes ADHD 
diagnosis challenging because its symptoms are often mistakenly 
assumed to be part of BD. As a result, patients with comorbid ADHD/BD 
are under-diagnosed and under-treated. Optimal diagnosis, 
understanding and treatment of the comorbid condition are important, as 
ADHD/BD has been associated with significant functional impairment 
and suboptimal treatment responses when compared to ADHD or BD 





One of the first reference to a hyperactive or ADHD child (Fidgety Phil) 
was in the poems of the German physician Heinrich Hoffman in 1865, 
who wrote poems about many of the childhood maladies who saw in his 
medical practice (Stewart, 1970).  But scientific credit is typically 
awarded to George Still and Alfred Tredgold for being the first authors to 
focus with serious clinical attention on the behavioral condition in 
children that most closely approximates what is today known as ADHD. 
Still, he believed these children displayed a major ―defect in moral 
control‖ in their behavior that was relatively chronic in most cases. In 
some cases, these children acquired the defect as a consequence of an 
acute brain disease, and it might remit on recovery from the disease. In 
the chronic cases, he noted a higher risk for criminal acts in later 
development in some of them, though not all. Although this defect could 
be associated with intellectual retardation, as it was in 23 of the cases, it 
could also arise in children of near normal intelligence as it seemed to 
happen in the remaining 20. 
The history of interest in ADHD in North America can be traced back to 
the outbreak of an encephalitis epidemic in 1917–1918 when clinicians 
had to face a number of children who survived this brain infection yet 
with significant behavioral and cognitive sequelae (Cantwell, 1981; 
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Kessler, 1980; Stewart, 1970). Numerous papers reported these 
sequelae (Ebaugh, 1923; Strecker & Ebaugh, 1924; Stryker, 1925), and 
they included many of the characteristics we now incorporate into the 
concept of ADHD. Such children were described as being impaired in 
their attention, regulation of activity, and impulsivity, as well as other 
cognitive abilities, including memory, and were often noted to be socially 
disruptive. Symptoms of oppositional and defiant behavior as well as 
delinquency and conduct disorder also arose in some cases. Post-
encephalitic Behavior Disorder, as it was called, was clearly the result of 
brain damage. The large number of children affected resulted in 
significant professional and educational interest in this behavioral 
disorder. Its severity was such that many children were recommended 
for care and education outside the home and normal educational 
facilities. Despite a rather pessimistic view of the prognosis of these 
children, some facilities reported significant success in their treatment 
using simple behavior modification programs and increased supervision 
(Bender, 1942; Bond & Appel, 1931). 
The association of a brain disease with behavioral pathology apparently 
led early investigators to study other potential causes of brain injury in 
children and their behavioral manifestations. Birth trauma (Shirley, 1939); 
other infections such as measles (Meyer & Byers, 1952), lead toxicity 
(Byers & Lord, 1943), epilepsy (Levin, 1938), and head injury (Blau, 
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1936; Werner & Strauss, 1941) were studied in children and were found 
to be associated with numerous cognitive and behavioral impairments, 
including the triad of ADHD symptoms noted earlier. Other terms 
introduced during this era for children displaying these behavioral 
characteristics were ―organic driveness‖ (Kahn & Cohen, 1934) and 
―restlessness‖ syndrome (Childers, 1935; Levin, 1938). Many of the 
children seen in these samples were also mentally retarded or more 
seriously behaviorally disordered than are children who are today 
diagnosed as ADHD. Only several decades later, however, investigators 
would have attempted to make out the separate contributions of 
intellectual delay, learning disabilities, or other neuropsychological 
deficits from those of the behavioral deficits to the maladjustment of 
these children. Even so, scientists at that time discovered that activity 
level was often inversely related to intelligence in children, increasing as 
intelligence declined—a finding supported in many subsequent studies 
(Rutter, 1989). It should also be noted that a large number of children in 
these older studies were, in fact, brain damaged or had signs of such 
damage (epilepsy, hemiplegias, etc.). 
Another significant series of papers on the treatment of hyperactive 
children appeared in 1937–1941. These papers were to mark the 
beginnings of medication therapy (particularly stimulants) for behaviorally 
disordered children as well as the field of child psychopharmacology in 
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general (Bradley, 1937; Bradley & Bowen, 1940; Molitch & Eccles, 
1937). Originally Initiated to treat headaches that resulted from pneumo-
encephalograms during research studies of these disruptive youth, the 
administration of amphetamine turned out in a noticeable improvement in 
their behavioral problems and academic performance. Later studies also 
confirmed such a positive drug response in half or more of hyperactive 
hospitalized children (Laufer, Denhoff, & Solomons, 1957). As a result, 
by the 1970s, stimulant medications were gradually becoming the 
treatment of choice for the behavioral symptoms now associated with 
ADHD. And so they remain today. 
In the 1950s, researchers began a number of investigations into the 
neurological mechanisms underlying these behavioral symptoms, the 
most famous of which was probably that by Laufer et al. (1957). These 
writers referred to ADHD children as having Hyperkinetic Impulse 
Disorder and stated that the central nervous system (CNS) deficit 
occurred in the thalamic area. Here, poor filtering of stimulation occurred, 
allowing an excess of stimulation to reach the cortex. The evidence was 
based on a study of the effects of the photo-Metrozol method in which 
the drug Metrozol is administered while flashes of light are presented to 
the child. The amount of drug required to induce a muscle jerk of the 
forearms along with a spike-wave pattern on the electroencephalogram 
serves as the measure of interest. Laufer et al. (1957) found that 
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hyperactive inpatient children required less Metrozol than nonhyperactive 
inpatient children to induce this pattern of response. This finding 
suggested that hyperactive children had a lower threshold for stimulation 
likely in the thalamic area.  
In the late 1950s and early 1960s, critical reviews began appearing 
questioning the concept of a unitary syndrome of brain damage in 
children. They also pointed out the logical fallacy that if brain damage 
resulted in some of these behavioral symptoms, these symptoms could 
be pathognomonic of brain damage without any other corroborating 
evidence of CNS lesions. Leading among these critical reviews were 
those of Birch (1964), Herbert (1964), and Rapin (1964), who questioned 
the validity of applying the concept of brain damage to children who had 
only equivocal signs of neurological involvement, not necessarily 
damage. A plethora of research followed on MBD children (see Rie & 
Rie, 1980, for reviews); in addition, a task force by the National Institute 
of Neurological Diseases and Blindness (Clements, 1966) recognized at 
least 99 symptoms for this disorder. The concept of MBD would die a 
slow death as it eventually became recognized as vague, over-inclusive, 
of little or no prescriptive value, and without much neurological evidence 
(Kirk, 1963).  
As dissatisfaction with the term ―MBD‖ was occurring, clinical 
investigators shifted their emphasis on the behavioral symptom thought 
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as the main characteristic of the disorder – i.e., hyperactivity.  And so the 
concept of a hyperactive child syndrome arose, described in the classic 
papers by Laufer and Denhoff (1957) and Chess (1960) and other 
reports of this era (Burks, 1960; Ounsted, 1955; Prechtl & Stemmer, 
1962). Chess defined hyperactivity as follows: ―The hyperactive child is 
one who carries out activities at a higher than normal rate of speed than 
the average child, or who is constantly in motion, or both‖. Chess‘s article 
was historically significant for several reasons: (1) it emphasized activity 
as the defining feature of the disorder, rather than speculative underlying 
neurological causes, as other scientists of the time would also do, (2) it 
stressed the need to consider objective evidence of the symptom beyond 
the subjective reports of parents or teachers, (3) it took the blame for the 
child‘s problems away from the parents, and (4) it separated the 
syndrome of hyperactivity from the concept of a brain-damaged 
syndrome. Other scientists of this era emphasized similar points (Werry 
& Sprague, 1970). It was recognized that hyperactivity is a behavioral 
syndrome that could arise from organic pathology but could also occur in 
its absence. Even so, it would continue to be viewed as the result of 
some biological difficulty rather than due solely to environmental causes. 
Hence arose the beginning of a belief that would be widely held among 




Also noteworthy in this era was the definition of hyperactivity given in the 
official diagnostic nosography at the time, the second edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-II; American 
Psychiatric Association, 1968). It employed only a single sentence 
describing the hyperkinetic features and, in the wake of Chess, stressed 
the view that the disorder was developmentally benign: ―The disorder is 
characterized by overactivity, restlessness, distractibility, and short 
attention span, especially in young children; the behavior usually 
diminishes by adolescence‖. 
It is likely during this period, or even earlier, that the perspective of 
hyperactivity in North America began to diverge from that in Europe, and 
particularly in Great Britain. In North America, hyperactivity would 
become a behavioral syndrome recognized mostly by greater-than-
normal levels of activity, would be viewed as a relatively common 
disturbance of childhood, would not necessarily be associated with 
demonstrable brain pathology or mental retardation, and would be more 
of an extreme degree in the normal variation of temperament in children. 
In Great Britain, the earlier and narrower view of a brain-injured child 
syndrome would continue into the 1970s -- hyperactivity or hyperkinesis 
was seen as an extreme state of excessive activity of an almost driven 
quality, was highly uncommon, and usually occurred in conjunction with 
other signs of brain damage, such as epilepsy, hemiplegias, retardation, 
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or a clearer history of brain insult, such as trauma or infection (Taylor, 
1988). The divergence in views would lead to large discrepancies 
between North America and Europe in their estimations of the 
prevalence of the disorder, their diagnostic criteria, and their preferred 
treatment modalities. A rapprochement between these views would not 
occur until well into the 1980s (Rutter, 1988, 1989; Taylor, 1986, 1988). 
As Ross and Ross (1976) noted in their exhaustive and scholarly review 
of the era, the perspective on hyperactivity in this historical period was 
that it remained a brain-dysfunction syndrome, although of a milder 
magnitude than previously believed. The disorder was no longer 
ascribed to brain damage; instead a focus on brain mechanisms 
prevailed. The disorder was also viewed as having a predominant and 
relatively homogeneous set of symptoms, prominent among which was 
excessive activity level or hyperactivity. Its prognosis was now felt to be 
relatively benign as it was often outgrown by puberty. The recommended 
treatments now consisted of short-term treatment with stimulant 
medication and psychotherapy in addition to the minimum-stimulation 
types of classrooms recommended in earlier years. 
Research in the period from 1970 to 1979  took a quantum leap forward, 
with more than 2,000 published studies existing by the time the decade 
ended (G. Weiss & Hechtman, 1979). Numerous clinical and scientific 
textbooks (Cantwell, 1975; Safer & Allen, 1976; Trites, 1979; Wender, 
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1971) appeared along with a most thorough and scholarly review of the 
literature by Ross and Ross (1976). Special journal issues were devoted 
to the topic (Douglas, 1976; Barkley, 1978), along with numerous 
scientific gatherings (Knights & Bakker, 1976, 1980). Clearly, 
hyperactivity had become a subject of serious professional, scientific, 
and popular attention. 
By the early 1970s, the defining features of the hyperactive or 
hyperkinetic child syndrome were broadened to include what 
investigators previously felt to be only associated characteristics, 
including impulsivity, short attention span, low frustration tolerance, 
distractibility, and aggressiveness (Marwitt & Stenner, 1972; Safer & 
Allen, 1976). Others (Wender, 1971, 1973) persisted with the excessively 
inclusive concept of MBD in which even more features, such as motor 
clumsiness, cognitive impairments, and parent–child conflict, were 
viewed as hallmarks of the syndrome and in which hyperactivity was 
unnecessary for the diagnosis. As noted earlier, the diagnostic term 
―MBD‖ would fade from clinical and scientific usage by the end of this 
decade, resulting in no small part of the scholarly tome by Rie and Rie 
(1980) and critical reviews by Rutter (1977, 1982). These writings 
emphasized the lack of evidence for such a broad syndrome.  The 
symptoms were not well defined, did not significantly correlate among 
themselves, had no well-specified etiology, and displayed no common 
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course and outcome. The heterogeneity of the disorder was 
overwhelming and the conceptualization of an MBD with little or no 
evidence of neurological abnormality was far and wide criticized 
(Wender, 1971). Moreover, even in cases of well-established cerebral 
damage, the behavioral sequelae were not uniform across cases and 
hyperactivity turned out only in a minority of cases. Hence, contrary to 25 
years of theorizing about this point, hyperactivity was not a common 
sequelae of brain damage, truly brain-damaged children did not display a 
uniform pattern of behavioral deficits, and children with hyperactivity 
rarely had substantiated evidence of neurological damage (Rutter, 1989). 
Wender (1971) described the essential psychological characteristics of 
children with MBD as consisting of six clusters of symptoms: (1) motor 
behavior, (2) attentional–perceptual cognitive function, (3) learning 
difficulties, (4) impulse control, (5) interpersonal relations, and (6) 
emotion.  
Wender theorized that these six domains of dysfunction could be best 
accounted for by three primary deficits: (1) a decreased experience of 
pleasure and pain, (2) a generally high and poorly modulated level of 
activation, and (3) extroversion. A consequence of item (1) is that MBD 
children would prove less sensitive to both rewards and punishments, 
making them less susceptible to social influence. The generally high and 
poorly modulated level of activation was thought to be an aspect of poor 
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inhibition. Hyperactivity, of course, was the consummate demonstration 
of this high level of activation. The problems with poor sustained 
attention and distractibility were conjectured to be secondary aspects of 
high activation. Emotional overreactivity, low frustration tolerance, 
quickness to anger, and temper outbursts resulted from the poor 
modulation of activation. These three primary deficits, then, created a 
cascading of effects into the larger social ecology of the child, resulting in 
numerous interpersonal problems and academic performance difficulties. 
Like Still (1902), Wender gave a prominent role to the low level of 
inhibition. He believed it could explain both the activation and the 
attention problems, as well as the excessive emotionality, low frustration 
tolerance, and hot temperedness of these children. It is therefore quite 
unclear why deficient inhibition was not made to be a primary symptom 
in this theory in place of high activation and poor modulation of 
activation. 
Unlike Still, however, Wender does not say much about normal 
developmental processes with respect to the three primary areas of 
deficit and thus does not clarify more precisely what may be going awry 
in them to give rise to these characteristics of MBD. The exception may 
be represented by the hypothesized lowered sensitivity to reinforcement 
and punishment. A higher-than-normal threshold for pleasure and pain, 
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as noted earlier, was thought to create these insensitivities to behavioral 
consequences. 
At this time, disenchantment developed over the exclusive focus on 
hyperactivity as the sine qua non of this disorder (Werry & Sprague, 
1970). Significant at this historical juncture would be the presidential 
address of Virginia Douglas to the Canadian Psychological Association 
(Douglas, 1972).  She argued that deficits in sustained attention and 
impulse control were more likely to account for the difficulties seen in 
these children than just hyperactivity. These other symptoms were also 
seen as the major areas on which the stimulant medications used to treat 
the disorder had their impact. Douglas‘s paper is historically significant in 
other ways as well. Her extensive and thorough battery of objective 
measures of various behavioral and cognitive domains, heretofore 
unused in research on ADHD, allowed her to rule in or out various 
characteristics felt to be typical for these children in earlier clinical and 
scientific lore. For instance, Douglas found that hyperactive children 
were not necessarily and uniformly more reading or learning disabled, 
did not perseverate on concept learning tasks, did not manifest auditory 
or right–left discrimination problems, and had no difficulties with short-
term memory. Most important, she and Susan Campbell demonstrated 
that hyperactive children were not always more distractible than normal 
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children and that the sustained attention problems could emerge in 
conditions in which no significant distractions existed. 
Douglas (1980a, 1980b, 1983; Douglas & Peters, 1979) later elaborated, 
refined, and further substantiated her model of hyperactivity; thus, her 
model culminated in the view that four major deficits could account for 
symptoms of ADHD: (1) the investment, organization, and maintenance 
of attention and effort; (2) the inhibition of impulsive responding; (3) the 
modulation of arousal levels to meet situational demands; and (4) an 
unusually strong inclination to seek immediate reinforcement. This 
perspective initiated or guided a substantial amount of research over the 
following 15 years. 
Douglas‘s paper and the subsequent research published by her team 
were so influential that they were probably the major reason the disorder 
was renamed Attention-Deficit Disorder (ADD) in 1980 with the 
publication of DSM-III (American Psychiatric Association, 1980). In this 
revised official taxonomy, deficits in sustained attention and impulse 
control were formally recognized as of greater significance in the 
diagnosis than hyperactivity. The shift to attention deficits rather than 
hyperactivity as the major difficulty of these children was useful, at least 
for a while, because of the growing evidence that hyperactivity was not 
specific of this particular condition but could be noted in other psychiatric 
disorders (anxiety, mania, autism, etc.), that there was no clear 
21 
 
delineation between normal and abnormal levels of activity, that activity 
was in fact a multi-dimensional pattern, and that the symptoms of 
hyperactivity were quite situational in many children (Rutter, 1989). But 
also this re-appraisal would have shown its weakness when a decade 
later similar objections began to be raised about the pattern of attention 
(multidimensional, situationally variable, etc.). Yet, some research 
showed that at least deficits in vigilance or sustained attention could be 
used to discriminate this disorder from other psychiatric disorders 
(Werry, 1988). 
Another hallmark of this era was the widespread adoption of the parent 
and teacher rating scales developed by C. Keith Conners (1969) for the 
assessment of symptoms of hyperactivity, particularly during trials on 
stimulant medication. For at least 20 years, these simply constructed 
ratings of behavioral items would be the ―gold standard‖ for selecting 
children as hyperactive for both research purposes and treatment with 
medication. The scales would also come to be used for monitoring of 
treatment responses during clinical trials. 
Also significant during this decade was the effort to study the social–
ecological impact of hyperactive/inattentive behavior. This line of 
research set about evaluating the effects produced on family interactions 
by the hyperactive child. Originally initiated by Campbell (1973, 1975), 
this line of inquiry dominated the research over the following decade 
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(Barkley & Cunningham, 1979; Cunningham & Barkley, 1978, 1979; 
Danforth et al., 1991), particularly evaluating the effects of stimulant 
medication on social exchanges. These studies showed that hyperactive 
children were much less compliant and more oppositional during parent–
child exchanges than normal children and that their mothers were more 
demanding, commanding, and negative than mothers of normal children. 
These difficulties would increase substantially when the situation 
changed from free play to task-oriented demands. Studies also 
demonstrated that stimulant medication resulted in significant 
improvements in child compliance and decreases in maternal control and 
directiveness. Simultaneously, Humphries, Kinsbourne, and Swanson 
(1978) reported similar effects of stimulant medication, all of which 
suggested that much of parental controlling and negative behavior 
toward hyperactive children were the result rather than the cause of the 
children‘s poor self-control and inattention. At the same time, Carol 
Whalen and Barbara Henker at the University of California, Irvine, 
demonstrated similar interaction conflicts between hyperactive children 
and their teachers and peers as well as similar effects of stimulant 
medication on these social interactions (Whalen & Henker, 1980; 
Whalen, Henker, & Dotemoto, 1980). This line of research was 
substantially increased in the following decade and was expanded by 
Charles Cunningham and others to include studies of peer interactions 
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and the effects of stimulants on them (Cunningham, Siegel, & Offord, 
1985). 
Finally, this decade should be credited with the emergence of clinical and 
research interests in the existence of MBD or hyperactivity in adult 
clinical patients. Initial interest in adult MBD can be traced back to the 
latter part of the 1960s, seemingly arising as a result of two events. The 
first of these was the publication of several early follow-up studies 
demonstrating persistence of symptoms of hyperactivity/MBD into 
adulthood in many cases (Mendelson et al., 1971; Menkes, Rowe, & 
Menkes, 1967). The second was the publication by Harticollis (1968) of 
the results of neuropsychological and psychiatric assessments of 15 
adolescent and young adult patients (ages 15–25) seen at the 
Menninger Clinic.  The neuropsychological performance of these patients 
suggested evidence of moderate brain damage. Their behavioral profile 
suggested many of the symptoms that Still initially identified in ADHD 
children, particularly impulsiveness, overactivity, mood lability, and 
proneness to aggressive behavior and depression. Some of the cases 
appeared to have demonstrated this behavior uniformly since childhood. 
Horticollis speculated using psychoanalytic theory that this condition 
arose from an early and possibly congenital defect in the ego apparatus 
in interaction with busy, action-oriented, successful parents. 
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The following year, Quitkin and Klein (1969) reported on two behavioral 
syndromes in adults that may be related to MBD. The authors studied 
105 patients at the Hillside Hospital in Glen Oaks, New York, for 
behavioral signs of ―organicity‖ (brain damage), behavioral syndromes 
that might be considered soft neurological signs of CNS impairment, as 
well as the results of electroencephalogram (EEG), psychological testing, 
and clinical presentation and history that might differentiate these 
patients from other types of adult psychopathology. The results were 
interpreted as being in conflict with the widely held beliefs at the time that 
hyperactive–impulsive behavior tends to wane in adolescence.  On the 
contrary, the authors argued that some of these children continued into 
young adulthood with this specific behavioral syndrome. Later into this 
decade, Morrison and Minkoff (1975) similarly argued that adult patients 
with explosive personality disorder or episodic dyscontrol syndrome may 
have been hyperactive children. They also suggested that 
antidepressant medications might be useful in their management, 
echoing the same suggestion made earlier by Huessy (1974) in a letter 
to the editor of a journal that both antidepressants and stimulants may be 
the most useful medications for the treatment of these hyperkinetic or 
MBD adults. But the first truly scientific evaluation of the efficacy of 
stimulants with adults having MBD must be credited to Wood, Reimherr, 
Wender, and Johnson (1976).  They used a double-blind, placebo-
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controlled method to assess response to methylphenidate in 11 of 15 
adults with MBD followed by an open trial of pemoline (another 
stimulant), and the anti-depressants imipramine and amitryptiline. The 
authors found that 8 of the 11 tested on methylphenidate had a favorable 
response whereas 10 of the 15 tested in the open trial showed a positive 
response to either the stimulants or antidepressants. The work of Pontius 
(1973) in this decade is historically notable for her proposition that many 
cases of adult MBD demonstrating hyperactive and impulsive behavior 
may arise from frontal lobe and caudate dysfunction. Such dysfunction 
would lead to ―an inability to construct plans of action ahead of the act, to 
sketch out a goal of action, to keep it in mind for some time (as an 
overriding idea) and to follow it through in actions under the constructive 
guidance of such planning‖.  
The decade closed with the prevailing view that hyperactivity was not the 
only or most important behavioral deficit seen in hyperactive children but 
poor attention span and impulse control were equally if not more 
important in explaining their problems. Brain damage was relegated to 
an extremely minor role as a cause of the disorder, at least in the realm 
of childhood hyperactivity/MBD, although other brain mechanisms, such 
as under-arousal or under-reactivity, brain neurotransmitter deficiencies 
(Wender, 1971), or neurological immaturity (Kinsbourne, 1977) were 
viewed as promising. Greater speculation about potential environmental 
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causes or irritants emerged, particularly diet and child rearing. Thus, the 
most recommended therapies for hyperactivity were not only stimulant 
medication but widely available special education programs, classroom 
behavior modification, dietary management, and parent training in child 
management skills. A greater appreciation for the effects of hyperactive 
children on their immediate social ecology was beginning to emerge, as 
was the impact of stimulant medication in altering these social conflicts. 
However, the sizable discrepancy in North American and European 
views of the disorder remained, with North American professionals 
continuing to recognize the disorder as more common, in need of 
medication, and more likely being an attention deficit while those in 
Europe viewed it as uncommon, defined by severe overactivity, and 
associated with brain damage. Those children in North America being 
diagnosed as hyperactive or attention deficit would likely be diagnosed 
as conduct disorder in Europe where treatment would be psychotherapy, 
family therapy, and parent training in child management.  Medication 
would be disparaged and little used. Nevertheless, the view that attention 
deficits were equally as important in the disorder as hyperactivity was 
beginning to make its way into European taxonomies (e.g., International 
Classification of Diseases, ninth revision [ICD-9], World Health 
Organization, 1978). Finally, some recognition occurred in this decade 
that there were adult equivalents of childhood hyperactivity or MBD that 
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they might be indicative of frontal-caudate dysfunction, and that these 
cases responded to the same medication treatments that had earlier 
been suggested for childhood ADHD—the stimulants and 
antidepressants. 
The exponential increase in research on hyperactivity characteristic of 
the 1970s continued unabated into the 1980s, making hyperactivity the 
most studied childhood psychiatric disorder. More books were written, 
conferences convened, and scientific papers presented during this 
decade than in any previous historical period. This decade would 
become known for its emphasis on attempts to develop more specific 
diagnostic criteria, the differential conceptualization and diagnosis of 
hyperactivity from other psychiatric disorders, and, later in the decade, 
critical attacks on the notion that inability to sustain attention was the 
core behavioral deficit in ADHD. 
Marking the beginning of this decade was the publication of DSM-III 
(American Psychiatric Association, 1980) and its radical 
reconceptualization (from that in DSM-II) of the Hyperkinetic Reaction of 
Childhood to that of Attention-Deficit Disorder (with or without 
Hyperactivity). The new diagnostic criteria were noteworthy not only for 
their greater emphasis on inattention and impulsivity as defining features 
of the disorder but also for their creation of much more specific symptom 
lists, an explicit numerical cutoff score for symptoms, specific guidelines 
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for age of onset and duration of symptoms, and the requirement of 
exclusion of other childhood psychiatric conditions as better explanations 
of the presenting symptoms. This was also a radical departure from the 
ICD–9 criteria set forth by the World Health Organization (1978) in its 
own taxonomy of child psychiatric disorders which continued to 
emphasize pervasive hyperactivity as a hallmark of this disorder. 
In that revision (DSM-III-R, American Psychiatric Association, 1987) only 
the diagnostic criteria for ADD+H were stipulated. ADD–H would no 
longer be officially recognized as a subtype of ADD but would be 
relegated to a minimally defined category: Undifferentiated ADD. This 
reorganization was associated with an admonition that far more research 
on the utility of this subtyping approach was necessary before its place in 
this taxonomy could be identified.  
At the same time that the DSM-III criteria for ADD (+/–H) were gaining in 
recognition, others attempted to specify research diagnostic criteria 
(Barkley, 1982; Loney, 1983).  
Concurrently, Loney (1983) and her colleagues had been engaged in a 
series of historically important studies that would differentiate the 
symptoms of hyperactivity or ADD+H from those of aggression or 
conduct problems (Loney, Langhorne, & Peternite, 1978; Loney & Milich, 
1982). Following an empirical/statistical approach to developing research 
diagnostic criteria, Loney demonstrated that a relatively short list of 
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symptoms of hyperactivity could be empirically separated from a similarly 
short list of aggression symptoms. Taylor‘s (1989) statistical approach to 
studying clusters of behavioral disorders pointed out that hyperactivity 
syndrome may represent a valid diagnostic entity, independent from 
other disorders, particularly conduct problems. This conceptualization 
required that the symptoms of hyperactivity and inattention are excessive 
and handicapping children, occur in two of three broadly defined settings 
(e.g., home, school, and clinic), are objectively measured rather than 
subjectively rated by parents and teachers, develop before age 6, last at 
least 6 months, and exclude children with autism, psychosis, or affective 
disorders (depression, anxiety, mania, etc.). 
Also important in this era was the attempt to identify useful approaches 
to subtyping other than those just based on the degree of hyperactivity 
(+H/–H) or aggression associated with ADD. A significant though under-
appreciated line of research by Roscoe Dykman and Peggy Ackerman at 
the University of Arkansas distinguished between ADD children with and 
without learning disabilities, particularly reading impairments. Their 
research (Ackerman, Dykman, & Oglesby, 1983; Dykman, Ackerman, & 
Holcomb, 1985) and that of others (McGee, Williams, Moffit, & Anderson, 
1989) showed that some of the cognitive deficits (verbal memory, 
intelligence, etc.) formerly attributed to ADHD were actually more a 
function of the presence and degree of language/reading difficulties than 
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of ADHD. And, although some studies showed that ADHD children with 
reading disabilities are not a distinct subtype of ADHD (Halperin, 
Gittelman, Klein, & Rudel, 1984), the differential contributions of reading 
disorders to the cognitive test performance of ADHD required that 
subsequent research studies carefully select subjects with pure ADHD 
not associated with reading disability.  If they did not, then they at least 
should identify the degree to which reading disorders exist in the sample 
and their effects on the cognitive test results. 
Others in this era attempted to distinguish between pervasive and 
situational hyperactivity where the former was determined by the 
presence of hyperactivity at home and school and the latter referred to 
hyperactivity in only one of these settings (Schachar, Rutter, & Smith, 
1981). It would be shown that pervasively hyperactive children were 
likely to have more severe behavioral symptoms, greater aggression and 
peer relationship problems, and poor academic achievement. A revision 
of DSM-III (DSM-III-R; American Psychiatric Association, 1987) 
incorporated this concept into an index of severity of ADHD.  British 
scientists even viewed pervasiveness as an essential criterium for the 
diagnosis of a distinct syndrome of hyperactivity (see earlier). However, 
research appearing at the end of the decade (Costello, Loeber, 
Stoutheimer-Loeber, 1991) demonstrated that such group differences 
were more likely the result of differences in the source of the information 
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used to classify the children (parents versus teachers) than to actual 
behavioral differences between the situational and pervasive subgroups. 
This did not mean that pervasiveness might not be a useful means of 
subtyping or diagnosing ADHD but that more objective means of 
establishing it were needed than just comparing parent and teacher 
ratings on a questionnaire. 
Later in the decade, in an effort to further improve the criteria for defining 
this disorder, the DSM was revised (American Psychiatric Association, 
1987) as noted above, resulting in the renaming of the disorder as 
Attention-Deficit Hyperactivity Disorder. The revisions were significant in 
several respects. First, a single item list of symptoms and a single cutoff 
score replaced the three separate lists (inattention, impulsivity, and 
hyperactivity) and cutoff score in DSM-III. Second, the item list was now 
based more on empirically derived dimensions of child behavior from 
behavior rating scales and the items and cutoff score underwent a large 
field trial to determine their sensitivity, specificity, and discriminating 
power to distinguish ADHD from other psychiatric disorders and normal 
children (Spitzer et al., 1990). Third, the need was stressed that one had 
to establish the symptoms as developmentally inappropriate for the 
child‘s mental age. Fourth, the coexistence of affective disorders with 
ADHD no longer excluded the diagnosis of ADHD. And, more 
controversially, the subtype of ADD without Hyperactivity was removed 
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as a subtype and relegated to a vaguely defined category, 
Undifferentiated ADD, which was in need of greater research on its 
merits. ADHD was now classified with two other behavioral disorders 
(Oppositional Defiant Disorder and Conduct Disorder) in a supra-ordinate 
family or category known as Disruptive Behavior Disorders in view of 
their substantial overlap or comorbidity in clinic-referred populations of 
children. 
During this decade, Herbert Quay adopted Jeffrey Gray‘s 
neuropsychological model of anxiety (Gray, 1982, 1987, 1994) to explain 
the origin of the poor inhibition evident in ADHD (Quay, 1987, 1988, 
1997). Gray identified both a behavioral inhibition system as well as a 
behavioral activation system as being critical to understanding emotion. 
He also stipulated mechanisms for basic nonspecific arousal and for the 
appraisal of incoming information that must be critical elements of any 
attempt to model the emotional functions of the brain. According to this 
theory, signals of reward serve to increase activity in the behavioral 
activation system (BAS), thus giving rise to approach behavior and the 
maintenance of such behavior. Active avoidance and escape from 
aversive consequences (negative reinforcement) likewise activate this 
system. Signals of impending punishment (particularly conditioned 
punishment) as well as frustrative nonreward (an absence of previously 
predictable reward) increase activity in the behavioral inhibition system 
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(BIS). Another system is the fight–flight system, which reacts to 
unconditioned punitive stimuli. 
Quay‘s use of this model for ADHD stated that the impulsiveness 
characterizing the disorder arose from diminished activity in the brain‘s 
BIS. This model predicted that those with ADHD could be less sensitive 
to such signals, particularly in passive avoidance paradigms (Quay, 
1987). The theory also specifies predictions that can be used to test and 
even falsify the model as it applies to ADHD. Finally, Quay predicted 
increased rates of responding by those with ADHD under fixed-interval or 
fixed-ratio schedules of consequences. Some of these predictions were 
supported by subsequent research; others either remained to be 
investigated more fully and rigorously or have not been completely 
supported by the available evidence (see Milich, Hartung, Martin, & 
Haigler, 1994; Quay, 1997). Nevertheless, the theory remains a viable 
one for explaining the origin of the inhibitory deficits in ADHD and 
continues to be deserving of further research. 
Another noteworthy development in this decade was the greater 
sophistication of research designs attempting to explore the unique 
features of ADHD relative to other psychiatric conditions rather than just 
in comparison to normal. As Rutter (1983, 1989) noted repeatedly, the 
true test of the validity of a syndrome of ADHD is the ability to 
differentiate its features from other psychiatric disorders of children, such 
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as affective or anxiety disorders, learning disorders, and particularly 
conduct disorders. Those studies that undertook such comparisons 
indicated that situational hyperactivity was not consistent in 
discriminating among psychiatric populations but that difficulties with 
attention and pervasive (home and school) hyperactivity were more 
reliable in doing so and were often associated with patterns of 
neuropsychological immaturity (Firestone & Martin, 1979; Gittelman, 
1988; McGee, Williams, & Silva, 1984a, 1984b; Rutter, 1989; Taylor, 
1988; Werry, 1988). 
The emerging interest in comparing ADD children with and without 
Hyperactivity (+/–H) furthered this line of inquiry by demonstrating 
relatively unique features of each disorder in contrast to each other (see 
Chapter 3) and to groups of learning-disabled and normal children 
(Barkley, DuPaul, & McMurray, 1990, 1991). Further strengthening the 
position of ADHD as a psychiatric syndrome was evidence from family 
aggregation studies that relatives of ADHD children had a different 
pattern of psychiatric disturbance from those children with Conduct 
Disorder or mixed ADHD and Conduct Disorder (Biederman, Munir, & 
Knee, 1987; Lahey et al., 1988). Purely ADHD children were more likely 
to have relatives with ADHD, academic achievement problems, and 
dysthymia, whereas those children with Conduct Disorder had a greater 
prevalence of Conduct Disorder, antisocial behavior, substance abuse, 
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depression, and marital dysfunction among their relatives. This finding 
led to speculation that ADHD had a different etiology from conduct 
disorder. The former was said to arise out of a biologically based 
disorder of temperament or a neuropsychological delay; the latter from 
inconsistent, coercive, and dysfunctional child rearing and management, 
was frequently associated with parental psychiatric impairment 
(Hinshaw, 1987; Loeber, 1990; Patterson, 1982, 1986). 
The 1980s also witnessed some advances in the tools of assessment in 
addition to those for treatment. The Child Behavior Checklist (CBCL; 
Achenbach & Edelbrock, 1983, 1986) emerged as a more 
comprehensive, more rigorously developed, and better-normed 
alternative to the Conners Rating Scales (Barkley, 1987). It would 
become widely adopted in research on child psychopathology in general, 
not just in ADHD, by the end of this decade. Other rating scales more 
specific for ADHD were also developed, such as the ACTeRS (Ullmann 
et al., 1984), the Home and School Situations Questionnaires (Barkley & 
Edelbrock, 1987; DuPaul & Barkley, 1992), the Child Attention Profile 
(see Barkley, 1987), and the ADHD Rating Scale-IV (DuPaul, 1991). 
Gordon (1983) developed, normed, and commercially marketed a small, 
portable, computerized device that administered two tests believed to be 
sensitive to the deficits in ADHD. One was a CPT measuring vigilance 
and impulsivity and the other was a direct reinforcement of low rates 
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(DRL) test assessing impulse control. This test became the first 
commercially available objective assessment device for evaluating 
ADHD children. Although the DRL test showed some promise in early 
research (Gordon, 1979), it was subsequently shown to be insensitive to 
stimulant medication effects (Barkley, Fischer, Newby, & Breen, 1988) 
and was eventually de-emphasized as useful in the diagnosis for ADHD. 
The CPT task, by contrast, showed satisfactory discrimination of ADHD 
from normal groups and was sensitive to medication effects (Barkley et 
al., 1988; Gordon & Mettelman, 1988). Although cautionary statements 
would be made that more research evidence was needed to evaluate the 
utility of the instrument (Milich, Pelham, & Hinshaw, 1985) and that its 
false-negative rate (misses of legitimate ADHD children) might be 
greater than that desired in a diagnostic tool, the device and others like it 
(Conners, 1995; Greenberg & Waldman, 1992) found a wide clinical 
following by the following decade. 
Developments also continued in the realm of treatments for ADHD. 
Comparisons of single versus combined treatments were more common 
during the decade (Barkley, 1989c), as was the use of more 
sophisticated experimental designs (Hinshaw, Henker, & Whalen, 1984; 
Pelham, Schnedler, Bologna, & Contreras, 1980) and mixed 
interventions (Satterfield, Satterfield, & Cantwell, 1981). Several of these 
developments in treatment require historical mention. The first was the 
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emergence of a new approach to the treatment of ADHD: cognitive-
behavioral therapy, or CBT (Camp, 1980; Douglas, 1980a; Kendall & 
Braswell, 1985; Meichenbaum, 1988). Founded on the work of Russian 
neuropsychologists (Vygotsky and Luria), North American developmental 
and cognitive psychologists (Flavell, Beach, & Chinsky, 1966), and early 
cognitive-behavioral theories (Meichenbaum, 1977), these approaches 
stressed the need to develop self-directed speech in impulsive children 
to guide their definition of and attention to immediate problem situations, 
to generate solutions to these problems, and to guide their behavior as 
the solutions were performed. Self-evaluation, self-correction, and self-
directed use of consequences were also viewed as important (Douglas, 
1980a, 1980b). Although first reports of the efficacy of this approach 
appeared in the late 1960s and the 1970s (Bornstein & Quevillon, 1976; 
Meichenbaum & Goodman, 1979), it was not until this decade that the 
initial claims of success with nonclinical populations of impulsive children 
were more thouroughly tested in clinical populations of ADHD children. 
The initial results were disappointing (Abikoff, 1987; Gittelman & Abikoff, 
1989). Generally, they indicated some degree of improvement in 
impulsiveness on cognitive laboratory tasks but insufficient to be 
detected in teacher or parent ratings of school and home ADHD 
behaviors and certainly not as effective as stimulant medication (Brown, 
Wynne, & Medenis, 1985). Many continued to see some promise in 
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these techniques (Barkley, 1981, 1989b; Meichenbaum, 1988; Whalen, 
Henker, & Hinshaw, 1985), particularly when they were implemented in 
natural environments by important caregivers (parents and teachers); 
others ended the decade with a challenge to those who persisted in their 
support of this approach to provide further evidence for its efficacy 
(Gittelman & Abikoff, 1989). Such evidence would not be forthcoming 
(see Chapter 15).  Later, even the conceptual basis for the treatment 
came under attack as being inconsistent with Vygotsky‘s theory of the 
internalization of language (Diaz & Berk, 1995). 
A second development in treatment was the publication of a specific 
parent-training format for families with ADHD and oppositional children. 
A specific set of steps for training parents of ADHD children in child 
behavior management skills was developed (Barkley, 1981) and refined 
(Barkley, 1987, 1997b). The approach was founded on a substantial 
research literature (Barkley, 1997b; Forehand & McMahon, 1981; 
Patterson, 1982) demonstrating the efficacy of differential attention and 
time-out procedures for treating oppositional behavior in children—a 
behavior frequently associated with ADHD.  
A similar increase in more sophisticated approaches occurred in this era 
in relation to the classroom management of ADHD children (Barkley, 
Copeland, & Sivage, 1980; Pelham et al., 1980; Pfiffner & O‘Leary, 1987; 
Whalen & Henker, 1980). These developments were based on earlier 
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promising studies in the 1970s with contingency management methods 
in hyperactive children (Allyon et al., 1975; see Chapter 15 for the details 
of such an approach). Although these methods may not produce the 
degree of behavioral change seen in the stimulant medications 
(Gittelman et al., 1980), they provide a more socially desirable 
intervention that can be a useful alternative when children have mild 
ADHD and cannot take stimulants or their parents decline the 
prescription.  More often these methods serve as an adjunct to 
medication therapy to further enhance academic achievement. 
Finally, medication treatments for ADHD expanded to include the use of 
the tricyclic antidepressants, particularly for those ADHD children with 
characteristics that contraindicated using a stimulant medication (e.g., tic 
disorders or Tourette syndrome) or for ADHD children with 
anxiety/depression (Pliszka, 1987). The work of Joseph Biederman and 
his colleagues at Massachusetts General Hospital (Biederman, 
Gastfriend, & Jellinek, 1986; Biederman, Baldessarini, Wright, Knee, & 
Harmatz, 1989) on the safety and efficacy of the tricyclic medications 
encouraged the rapid adoption of these drugs by many practitioners (see 
Ryan, 1990), particularly when the stimulants, such as Ritalin 
(methylphenidate), were receiving such negative publicity in the popular 
media (see the next section). Simultaneously, initially positive research 
reports appeared on the use of the antihypertensive drug, clonidine, in 
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the treatment of ADHD children, particularly those with very high levels of 
hyperactive–impulsive behavior and aggression (Hunt, Caper, & 
O‘Connell, 1990; Hunt, Minderaa, & Cohen, 1985) 
history of this disorder, chief among them being the increase in research 
on the neurological and genetic basis of the disorder and on ADHD as it 
occurs in clinic-referred adults. 
Researchers have long-suspected that ADHD was associated in some 
way with abnormalities or developmental delays in brain functioning. 
Supporting such an interpretation are numerous neuropsychological 
studies showing deficits in performance by ADHD children on tests that 
were presumed to assess frontal lobe or executive functions (Barkley, 
1997b; Barkley et al., 1992; Goodyear & Hynd, 1992, for reviews). 
Moreover, psychophysiological research in earlier decades had 
suggested brain underactivity, particularly in functioning related to the 
frontal lobes (Hastings & Barkley, 1978; Klorman, 1992). And thus there 
is good reason to suspect that delayed or disturbed functioning in the 
brain, and particularly the frontal lobes, may be involved in this disorder. 
In 1990, Alan Zametkin and his colleagues at the National Institute of 
Mental Health (NIMH; Zametkin et al., 1990) published a landmark study.  
The authors evaluated brain metabolic activity in 25 adults with ADHD 
who had a childhood history of the disorder and who also had children 
with the disorder. The authors used positron emission tomography 
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(PET), an exceptionally sensitive technique for detecting states of brain 
activity and its localization within the cerebral hemispheres. The results 
of this study indicated significantly reduced brain metabolic activity in 
adults with ADHD relative to a control group, primarily in frontal and 
striatal regions. Such results were certainly consistent in many, though 
not all, respects with the earlier demonstrations of reduced cerebral 
blood flow in the frontal and striatal regions in children with ADHD (Lou 
et al., 1984, 1989). Significant in the Zametkin et al. (1990) study, 
however, was its use of a much better defined sample of ADHD patients 
and its focus on adults with ADHD. Although later attempts by this 
research team to replicate their original results using teenagers with 
ADHD were consistent with these initial results for girls with ADHD, no 
differences were found in boys with ADHD (see Ernst, 1996, for a 
review). Sample sizes in these studies were quite small, however, almost 
ensuring some difficulties with the reliable demonstration of the original 
findings. Despite these difficulties, the original report stands out as one 
of the clearest demonstrations to date of reduced brain activity, 
particularly in the frontal regions, in ADHD. 
At the same time as the NIMH research using PET scans was appearing, 
other researchers were employing magnetic resonance imaging (MRI) to 
evaluate brain structures in children with ADHD. Hynd and his 
colleagues were the first to use this method and they focused on the total 
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brain volume as well as specific regions in the anterior and posterior 
brain sections. Children with ADHD were found to have abnormally 
smaller anterior cortical regions, especially on the right side, and they 
lacked the normal right–left frontal asymmetry (Hynd, Semrud-Clikeman, 
Lorys, Novey, & Eliopulis, 1990). Subsequent research by this team 
focused on the size of the corpus callosum, finding that both the anterior 
and posterior portions were smaller in children with ADHD (Hynd et al., 
1991); however, in a later study, only the posterior region was 
significantly smaller (Semrud-Clikeman et al., 1994). Additional studies 
were reported by Hynd et al. (1993), who found a smaller left caudate 
region in children with ADHD, and Giedd et al., (1994), who found 
smaller anterior regions of the corpus callosum (rostrum and rostral 
body). 
More recently, two research teams published studies using MRI with 
considerably larger samples of ADHD children (Castellanos et al., 1994, 
1996; Filipek et al., 1997). These studies documented significantly 
smaller right prefrontal lobe and striatal regions in children with ADHD. 
Castellanos et al. (1996) also found smaller right-sided regions of 
structures in the basal ganglia, such as the striatum, as well as the right 
cerebellum. Filipek et al. (1997) observed the left striatal region to be 
smaller than the right. Despite some inconsistencies across these 
studies, most have implicated the prefrontal-striatal network as being 
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smaller in children with ADHD with the right prefrontal region being 
smaller than the left. Such studies have placed on a considerably firmer 
foundation the view that ADHD does, indeed, involve impairments in the 
development of the brain, particularly in the prefrontal-striatal regions, 
and that the origin of these differences from normal are likely to have 
occurred in embryological development (Castellanos et al., 1996). 
Advances in neuroimaging technology continue to provide exciting and 
revealing new developments in the search for the structural differences 
in the brain that underlie this disorder. For instance, the advent of 
functional MRI with its greater sensitivity for localization of activity has 
already resulted in a number of newly initiated investigations into 
possible impairments in these brain regions in children and adults with 
ADHD. 
 
ADHD IN CHILDREN AND ADOLESCENTS  
 
ADHD is a neurobehavioral developmental disorder. It is primarily 
characterized by "the co-existence of attentional problems and 
hyperactivity, with each behavior occurring infrequently alone" and 
symptoms starting before seven years of age. 
ADHD is the most commonly studied and diagnosed psychiatric disorder 
in children, affecting about 3 to 5 percent of children globally and 
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diagnosed in about 2 to 16 percent of school aged children (Kessler et al, 
2006). It is a chronic disorder with 30 to 50 percent of individuals 
diagnosed in childhood continuing to have symptoms in adulthood. 
Adolescents and adults with ADHD tend to develop coping mechanisms 
to compensate for some or all of their impairments. It is estimated that 
4.7 percent of American adults live with ADHD. Standardized rating 
scales such as WHO‘s Adult ADHD Self-Report Scale can be used for 
ADHD screening and assessment of the disorder‘s symptoms severity. 
ADHD is diagnosed two to four times more frequently in boys than in 
girls, though studies suggest this discrepancy may be partially due to 
subjective bias of referring teachers. ADHD management usually 
involves some combination of medications, behavior modifications, 
lifestyle changes, and counseling. The clinical picture can be difficult to 
be differentiated from other disorders, increasing the likelihood that the 
diagnosis of ADHD may be missed. Additionally, most clinicians have not 
received formal training in the assessment and treatment of ADHD, 
particularly in adult patients (Barkley 2006). 
ADHD and its diagnosis and treatment have been considered 
controversial since the 1970s. The controversies have involved 
clinicians, teachers, policymakers, parents and the media. Topics include 
the definition of the disorder, its causes, and the use of stimulant 
medications in its treatment. Most healthcare providers accept that 
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ADHD is a genuine disorder with debate in the scientific community 
focusing mainly on how it is diagnosed and treated. The American 
Medical Association concluded in 1998 that the diagnostic criteria for 
ADHD are based on extensive research and, if applied appropriately, 
lead to the diagnosis with high reliability. 
ADHD may accompany other disorders such as anxiety or depression. 
Such combinations can greatly complicate diagnosis and treatment. 
Academic studies and research in private practice suggest that 
depression in ADHD appears to be increasingly prevalent in children as 
they get older, with a higher rate of increase in girls than in boys, and to 
vary in prevalence on the basis of the subtype of ADHD. Where a mood 
disorder complicates ADHD it would be prudent to treat the mood 
disorder first, even if parents often wish to have the ADHD treated first, 
because the response to treatment is quicker (Barkley, 2006). 
Inattention and "hyperactive" behavior are not the only problems in 
children with ADHD. ADHD exists alone in only about 1/3 of the children 
diagnosed with it. Many co-existing conditions require other strategies of 
treatment and should be diagnosed separately instead of being grouped 
in the ADHD diagnosis. Some of the associated conditions are: 
 Oppositional defiant disorder (35%) and conduct disorder (26%) which 
both are characterized by antisocial behaviors such as stubbornness, 
aggression, frequent temper tantrums, deceitfulness, lying, or stealing, 
46 
 
inevitably linking these comorbid disorders with antisocial personality 
disorder (ASPD); about half of those with hyperactivity and ODD or CD 
develop ASPD in adulthood. 
 Borderline personality disorder, which was, according to a study on 120 
female psychiatric patients diagnosed and treated for BPD, associated 
with ADHD in 70 percent of the sample (Krull KR, 2007). 
 Primary disorder of vigilance, which is characterized by poor attention 
and concentration, as well as difficulties in staying awake. These 
children tend to fidget, yawn and stretch and appear to be hyperactive 
in order to remain alert and active. 
 Mood disorders. Boys diagnosed with the combined subtype have been 
shown likely to suffer from a mood disorder (Bauermeister, J., et al. 
2007) 
 Bipolar disorder. As many as 25 percent of children with ADHD have 
bipolar disorder. Children with this combination may demonstrate more 
aggression and behavioral problems than those with ADHD alone (Krull 
KR, 2007). 
 Anxiety disorder, which has been found to be common in girls 




 Obsessive-compulsive disorder. OCD is believed to share a genetic 
component with ADHD as well as many of its characteristics (Krull KR, 
2007). 
Methods of treatment often involve some combination of behavior 
modification, life-style changes, counseling, and medication. A 2005 study 
found that medical management and behavioral treatment is the most 
effective ADHD management strategy, followed by medication alone, and 
then behavioral treatment (Jensen PS et al, 2005) While medications have 
been shown to improve behavior when taken over the short term, they 
have not been shown to alter long term outcomes. Medications have at 
least some effect in about 80% of subjects. 
The evidence is strong for the effectiveness of behavioral treatments in 
ADHD. It is recommended as first choice in those who have mild 
symptoms and in preschool aged children (Kratochvil et al, 2009). 
Psychological therapies include psychoeducation, behavioral therapy, 
cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), 
family therapy, school-based interventions, social skills training and parent 
management training. 
Parent training and education have been found to have short term benefits 
(Pliszka S, 2007)). Family therapy has shown to be of little use in the 
treatment of ADHD, though it may be worth noting that parents of children 
with ADHD are more likely to divorce than parents of children without 
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ADHD, particularly when their children are younger than eight years old. 
Several ADHD specific support groups exist as informational sources and 
to help families cope with challenges associated with dealing with ADHD. 
Methylphenidate (Ritalin) 10 mg tablets stimulant medications are the 
medical treatment of choice (Wigal SB, 2009). There are a number of non-
stimulant medications, such as atomoxetine, which may be used as 
alternatives. There are no good studies of comparative effectiveness 
among various medications, and there is a lack of evidence on their effects 
on academic performance and social behaviors. While stimulants and 
atomoxetine are generally safe, there are side effects and 
contraindications related to their use (Wigal SB, 2009)). Medications are 
not recommended for preschool children, as their long-term effects in such 
young people are unknown. There is very little data on the long-term 
adverse effects or benefits of stimulants for ADHD (King S et 
al,2006).Guidelines on when to use medications vary internationally, with 
the UK's National Institute of Clinical Excellence, for example, only 
recommending use in severe cases, while most United States guidelines 
recommend medications in nearly all cases. 
As far as prognosis is concerned, children diagnosed with ADHD have 
significant difficulties in adolescence, regardless of treatment. In the United 
States, 37 percent of those with ADHD do not get a high school graduation 
even though many of them will receive special education services (Barkley 
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2006). In the US, less than 5 percent of individuals with ADHD get a 
college degree compared to 28 percent of the general population. Children 
with ADHD are at high risk of adverse life events once they become 
teenagers. These events include road accidents, different kind of injuries, 
early sexual activity, and teen pregnancy. Russell Barkley states that adult 
ADHD impairments affect "education, occupation, social relationships, 
sexual activities, dating and marriage, parenting and offspring 
psychological morbidity, crime and drug abuse, health and related 
lifestyles, financial management, or driving. ADHD can be found to 
produce diverse and serious impairments". The proportion of children 
meeting the diagnostic criteria for ADHD drops by about 50 percent over 
three years after the diagnosis. This occurs regardless of the treatments 
used and also occurs in untreated children with ADHD.ADHD persists into 
adulthood in about 30 to 50 percent of cases (Kessler et al, 2006). 
Subjects affected are likely to develop coping mechanisms as they mature, 




The study of the prevalence of ADHD in Western countries has provided 
very different results, due to the heterogeneity of diagnostic approaches, 
particularly between the USA and Europe. Even if the greatest 
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prevalence of the disorder in the United States has been linked to the 
exposure to high-technology products (synthetic food additives, leaded 
petrol, dyes), it is very likely to be due to a different diagnostic sensitivity.  
ADHD is highly prevalent among the general population. It is believed 
that 3-7% of school age subjects are affected with a 4:1 ratio between 
males and females (10% vs. 2%). The prevalence observed among 
preschool age children is 2-8% and it rises to 4-12% among primary 
school children, diminishing to approximately 6% in adolescence 
(Kessler et al., 2006). 
Vast amounts of evidence suggest a higher prevalence of inattentive 
forms in females, and hyperactive and impulsive forms in males among 
whom it is possible to encounter a more frequent comorbidity with 
externalizing disorders (Oppositional-defiant disorder, Conduct disorder). 
ADHD in the US constitutes about 30-40% of users of developmental 
age psychiatry services, and it is present in 40-70% of psychiatric 
patients subjected to treatment. In the mid-80s about 2-4% of the 
American school population received psychiatric treatment with 
psychostimulants, while at the end of the 80s public campaigns by the 
Scientist Church had caused a reduction in the clinical use of this 
category of drugs (Safer and Krager, 1992). 
Between 1990 and 1995 there was a new 2,5-fold increase in the use of 
stimulants in the United States.  
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As far as adul population is concerned, until a few years ago studies 
were limited to a rough estimation based on data on prevalence and 
prognosis in childhood, taking into account that the symptomatology tend 
to persist in 50% of cases and that  the disorder does not occur ex novo 
in adults (Harpin, 2005; Hechtman, 2000; Mannuzza et al., 1993).  
Recently, epidemiological studies, such as the National Comorbidity 
Survey, carried out on an adult population of 10.000 subjects, show a 
prevalence of 4,4% with a higher frequency in the predominantly 
inattentive type when compared to the other two types (Kessler et al., 
2006); these data have been confirmed in subsequent studies 
(Klassenm, 2010; Wilens, 2009). 
In a study carried out on a sample of 102 subjects from a penitentiary, 
25,5% of them met the diagnostic criteria for ADHD. This data reflect the 
highest incidence of psychopathology and psychiatric comorbidity in 
prisoners. 
 
NOSOLOGY AND DIAGNOSIS 
 
Before the introduction of the operational criteria of DSM III (1980), the 
syndrome was considered to be composed of behavioural, motor, 
cognitive and sensory-perceptual deficits, including a wide variety of 
symptoms such as hyperactivity, inattention, distractibility, impulsiveness, 
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lability of mood, irritability, prematuraty, disobedience, hostility, dyslexia, 
or other learning disabilities. 
With DSM III, hyperactivity is no longer seen as a cornerstone of the 
syndrome, while inattention (attention deficit disorder) is considered a 
primary element together with impulsivity and hyperactivity as 
complementary elements.   
For these reasons DSM III is defined as an attention deficit disorder 
(ADD). In the third revised edition of DSM III-R, (1987), hyperactivity is 
diagnostically re-emphasised and the syndrome is defined as "Attention 
deficit hyperactivity disorder". 
With the publication of DSM IV (1994), the attention deficit regains its 
importance. Impulsivity and hyperactivity remain included in the list of 
criteria.   
DSM IV places ADHD into the sphere of childhood and adolescent 
disorders with a division into three types:  
1. predominantly inattentive;  
2. predominantly hyperactive- impulsive,  
3. combined. 
In DSM III-R there are no criteria for the diagnosis of a residual or 
persistent form in adulthood, while DSM IV specifically defines ―ADHD in 
partial remission‖ in adolescents and adults who no longer meet the full 
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criteria. ICD 10 instead offers a diagnosis of ―hyperkinetic syndrome‖ 
characterised by impulsivity, aggressiveness and inattention, often 
accompanied by a history of perinatal or neonatal damage. 
 The DSM-IV-TR criteria (Table 1) for the diagnosis of ADHD are valid 
only for children and adolescents, yet when extended to adults it can be 
seen that their sensitivity and specificity are somewhat limited.  
Criterion A requires the persistence of at least 6 symptoms of inattention 
and/or hyperactivity-impulsivity for a period of at least 6 months, with an 
intensity that causes maladjustment and which is in contrast with the 
level of development. Criterion B sets the age of onset of some  
symptoms that cause impairment under 7 years of age. Criterion C 
indicates the presence of a malfunction in two or more contexts (work, 
school, family).  Several authors (Heiligenstein et al., 1998; Barkley, 
2006) stress that the  symptomatological pattern of an adult affected by 
ADHD often changes in time and is mainly characterised by the 
attenuation of some symptoms (hyperactivity and impulsivity) and by the 
chronicity and persistence of others (inattention). In addition, comorbidity 
with other psychiatric pathologies such as mood disorders, anxiety and 
disorders deriving from use of substances can hide the attention deficit 
and the impulsivity, thus favouring an underestimation of the disorder. 
Finally, problems that patients run into in adulthood arise within contexts 
and situations (marriage, children, work) that differ from those in age of 
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development with a different emotional and practical impact. Studies that 
adopt the DSM-IV-TR criteria exclude some potential cases of ADHD 
that do not fully meet the criteria, although they do show maladjustment 
in several areas. In fact, it has been noticed that the presence of at least 
6 symptoms of inattention and/or hyperactivity- impulsivity is an 
excessively restrictive and not a very realistic criterion in the adult 
population. For this reason there are many studies which adopt 
alternative diagnostic systems such as the Utah criteria for adult ADHD 
proposed by Wender (Table 2).  
Several authors have also highlighted the need of specific diagnostic 
criteria based on the age of the subject, validated by studies exclusively 
carried out on adults (Murphy and Barkley 1996; Faraone et al., 2000).  
Self-assessment scales, such as the Conner’s Adult ADHD Rating 
Scales (CAARS) and Wender Utah Rating Scales (WURS), or others that 
require the presence of a family member, such as ADHD Rating Scales-
IV, can be used for an adult. The use of neuropsychological tests (Stroop 
tasks e Continuous performance tests) is aimed to evaluate cognitive 
functions and they can also be useful in monitoring the effectiveness of 
treatments. 
Nosographic problems of ADHD in adults include: full correspondence 
with the diagnostic criteria of DSM-IV, appropriateness of the 
development of symptoms, age criterion, validity of the diagnosis of 
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ADHD not otherwise specified (NOS), comorbidity with other mental 
disorders. 
Currently the diagnosis in an adult can be formulated only if all the 
criteria of ADHD for children are fullfilled. If this condition is not fully 
satisfied, subjects can be classified as ADHD NOS. In most cases this 
category comprehends late-onset ADHD and subthreshold ADHD. In the 
first case the patient meets all the criteria of ADHD for children except 
the onset before 7 years of age. In the second case the patient has 
never received a diagnosis of ADHD as a child; however, there are 
persistent and disabling symptoms. 
Most patients with late-onset ADHD (83%) reported that the symptoms 
first appeared before the age of 12 (Faraone et al., 2006). This would 
suggest that the age criterion currently used in DSM-IV is too restrictive.       
The presence of a psychiatric comorbidity can complicate the diagnosis 
because symptoms of diferent disorders may be overlapping. For 
instance, bipolar-disorder is often characterised by hyperactivity, 
inattention, loquacity, work impairment and impulsiveness, which are 
symptoms of ADHD as well (Klassen, 2010).      
For patients with SUD (substance use disorder) there are further specific 
issues: alcohol and substance abuse can sham symptoms of ADHD, it 
may be more difficult to find the overall data necessary for the diagnosis, 
and finally, the diagnosis of ADHD is relatively unknown and rarely 
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advanced by health workers charged with the treatment of substance 
abuse. 
Many substances themselves can cause the appearance of symptoms 
similar to those of ADHD. Cocaine causes psychomotor agitation and 
restlessness, and similar phenomena can occur also in syndromes 
caused by abstinence.  
Patients affected by SUD usually find it difficult to recall their childhood 
symptoms because of cognitive impairment related to the chronic and 






A high percentage of subjects affected by ADHD suffer from another 
psychiatric disorder. This percentage would be 80% in adults (Klassen at 
al, 2010). The literature refers to comorbidity with many conditions such 
as oppositional-defiant disorder, conduct disorder, obsessive-compulsive 
disorder, substance use disorder, mood disorders, anxiety disorders, 
Tourette‘s syndrome, learning disabilities, mental retardation, and 
borderline personality disorder.                 
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It is estimated that 25-75% of adolescents affected by ADHD also meet 
the criteria for Oppositional Disorder and Conduct Disorders (Barkley, 
2006), and that this condition is associated with a worse prognosis in 
terms of adaptation and responding to treatments. In a vast case history 
of subjects between 9 and 16 years old affected by ADHD, mood 
disorder was found in 48% of the cases, oppositional and conduct 
disorder in 36% and anxiety disorder in 36% (Bird et al., 1993). In a 
study carried out from 1988 to 2003, 280 patients affected by ADHD 
were compared to 142 patients with a negative diagnosis, all aged 
between 6 and 18 years. At the end of the study, the subjects affected by 
ADHD showed a higher risk of developing bipolar disorder, major 
depressive disorder or conduct disorder (Biederman, 2009). 
For some authors, ADHD and conduct disorder are two indistinguishable 
clinical entities because of a complete symptomatological overlap, 
whereas for others they are partially or totally independent. The latter 
hypothesis is supported by researches that compare family aggregation 
models and cognitive performances. Loney and coll. have observed that 
the co-presence of ADHD and conduct disorder in childhood evolves into 
aggressive behaviour and tendency to commit crimes during 
adolescence. Vice versa, ADHD without conduct disorder can evolve into 
cognitive and school deficits (Loney, 1980; Mc Gee et al., 1984). Other 
studies have shown that children affected by ADHD in comorbidity with 
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conduct disorder have a worse course and less therapeutic response 
than children affected by ADHD without conduct disorder (Biederman et 
al., 1991). It is interesting to make a comment about the gender 
difference in these disorders. Conduct disorders are two times more 
common in males than in females. Moreover, they are often the main 
reason why male children affected by ADHD can be identified and 
treated. Therefore, it is probable that some female children may not be 
diagnosed with this disorder. Considering that the prevalence rates of 
ADHD in children vary by sex in ratio between 3:1 and 10:1, it is easy to 
suspect that this difference may be partly justified by the lack of 
identification of a certain number of cases in female subjects 
(Biederman, 2004). 
A similar difference can be encountered in Antisocial Personality 
Disorder (diagnosed in adults), since men affected by ADHD receive this 
diagnosis more frequently than women. With regards to the prevalence 
of Oppositional-Defiant Disorder, the rates are almost identical in both 
sexes, both in childhood and in adulthood (Biederman, 2004).  
The literature widely reports an overlapping between ADHD and learning 
disabilities. Bad school performance in children affected by ADHD may 
be linked to inattention and impulsivity (characteristics of the disorder), to 
cognitive deficits or other factors such as a social disadvantage and 
demoralization. ADHD and learning disabilities are probably separate 
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entities, since the former is a behavioural disorder while the latter include 
deficits of various cognitive processes such as language, reading, 
writing, or calculation. In addition, many children affected by ADHD do 
not have learning problems and not all children affected by a learning 
disability have ADHD. 
Several studies point out a strong comorbidity between ADHD and 
anxiety disorders in adults, underlining a prevalence of Generalized 
Anxiety Disorder in 24-43% of patients (Barkley et al., 1996; Minde et al., 
2003; Shekim et al., 1990). In 2006, Togersen and coll. noticed in their 
patients affected by ADHD a life-time prevalence of panic disorder in 
13% and of social phobia in 18% of them. But there are also studies 
where no significant comorbidity between ADHD and anxiety disorders in 
adults was found (Murphy e Barkley, 1996; Barkley et al., 2001). 
The research data on comorbidity between ADHD and Obsessive-
Compulsive Disorder are controversial. Obsessive-compulsive 
personality traits can be found in a certain number or patients (Nadeau 
2005). However, many adults affected by ADHD feel the need to be strict 
and inflexible in order to inhibit traits of impulsivity, or become indecisive 
and unable to make decisions that, when taken, are impulsive and 
disastrous.  
Tourette‘s Disorder is characterised by the presence of multiple motor 
tics with onset before the age of 18. Patients affected by this disorder 
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show symptoms of ADHD in 50% of the cases (Comings and Comings 
1990). Symptoms of the disorder generally appear between 2 and 15 
years of age. Studies carried out on children with a case history of ADHD 
and Tourette‘s Disorder have shown that the symptoms of ADHD appear 
earlier than those of Tourette‘s Disorder (Comings, Comings et al. 1989). 
 
ADHD AND BIPOLAR DISORDER 
 
With regards to comorbidity with a mood disorder, major depression 
seems to be highly prevalent among children affected by ADHD, 
particularly in those with a conduct disorder (Angold et al., 1999). For 
adults, several researches show comorbidity between major depression 
and ADHD between 16 – 31% of all cases (Barkley et al., 2006; 
Biederman et al., 1993; Schubiner et al., 1995). Yet there are some 
follow-up studies that have documented an increased risk of depression 
in hyperactive children monitored until adulthood (Weiss et al., 1993).  
There is a significant comorbidity between ADHD and bipolar disorder, 
and it has been hypothesised that the former can be, at least in some 
cases, a prodromal form of the latter (Bizzarri, Rucci et al. 2007). Ryden 
and coll. noted how the clinical impact of a diagnosis of ADHD in children 
and adolescents on the course of Bipolar Disorder persists in a 
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pejorative sense in adulthood, regardless of whether the criteria for the 
diagnosis of ADHD continue or not to be satisfied (Ryeden, 2009). 
The symptomatic overlap between ADHD and bipolar disorder 
sometimes makes it difficult to formulate a differential diagnosis between 
the two conditions. Although there are several symptoms in common 
such as loquacity, distractibility, impulsive behaviour, hyperactivity, low 
critical capacity and underestimation of existential problems, it is clinically 
possible to point out some differences. 
The symptoms of ADHD tend to assume a chronic course, while in 
bipolar disorder the course is episodic. Patients affected by ADHD do not 
experience a rise in purposive activity, a reduced need of sleeping nor 
hypertrophic self-esteem, which are all characteristics of the main 
phases of Bipolar Disorder. Finally, mania may present psychotic 
symptoms such as hallucinations and delusions which are absent in 
subjects affected by ADHD. 
Compared to bipolar disorder, the symptoms of ADHD are characterised 
by an earlier onset, a persistent course, absence of euphoria, elation and 
psychotic phenomena, and generally less severe hyperactivity and 
impulsivity if compared to mania. Despite these differential features, 
controversies remain on the symptomatic overlapping and on the 
possible diagnostic difficulties in epidemiological and clinical studies.  
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Sentissi and coll. evaluated the prevalence of comorbid ADHD in bipolar 
patients during euthymic phase reporting a rate of 30% (Sentissi, 2008). 
Sachs G.S. et al. have suggested that Bipolar Disorder + ADHD can be 
considered a diagnostic subtype within the bipolar spectrum, 
characterised by a heavy genetic load and very early onset mood (Sachs 
et al., 2000). This is in line with the clinical observation that in subjects 
affected by bipolar disorder and ADHD, a worse outcome in terms of 
quality of life, global adaptation and risk of suicide is recorded (Tamam et 
al., 2008; Klassen, 2010). On this subject, it is important to note that 
these patients are poorly compliant to treatments (Klassen, 2010). 
Finally, it should be kept in mind that bipolar disorder in ADHD may be 
triggered by stimulants and antidepressants (Faedda e Teicher, 2005; 
Ross, 2006), even if data in this field are controversial.  
The rates of comorbidity of Bipolar Disorder in subjects affected by 
ADHD are extremely variable, from 5,1% to 47,1%. This heterogeneity 
can be attributed to the diagnostic criteria in use, to the different 
selection methods of case histories, and to the scarcity of case histories. 
For the same reasons, also the prevalence of ADHD in subjects affected 





ADHD AND SUBSTANCE USE DISORDER 
 
Substance Use Disorder (SUD) is widely diffused among the general 
population and it is estimated that 27% of adult population suffers from it 
(Kandel et al., 1997). Of them, 15-25% show symptoms of ADHD 
(Wilens, 2004), three times higher a percentage than that found among 
the general population. Similarly, ADHD seems to constitute a risk factor 
for the development of SUD. In fact, the percentage of patients affected 
by SUD among adults with ADHD is more than 40%, basically three 
times the prevalence rate of SUD among the general population, 
estimated at around 14,6% (Kessler, Adler et al. 2006). 
From a comparison of 120 adults affected by ADHD with 268 adults not 
affected by ADHD, with an average age of 40 years, it was found that the 
life-time prevalence of SUD was present in 52% of patients with ADHD 
and in 27% of those without it (Biederman et al., 1995). Further studies 
have shown that adults affected by ADHD in comorbidity with Bipolar 
Disorder or Conduct Disorder are at a higher risk of getting a SUD 
(Wilens et al., 1998). 
In short, the source literature is unanimous in stating that there is a 
mutual connection between SUD and ADHD, and that patients with both 
disorders are subjects to a worse outcome. Arias and colleagues have 
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found out from a sample of 1761 adults diagnosed with an addiction to 
cocaine and/or opioids that more comorbidities with other psychiatric 
disorders can be found in subjects affected by ADHD, together with a 
worse course of the illness identified by a higher numbers of 
hospitalisations, suicide attempts and self-harming behaviour (Arias et 
al., 2008). In this case history, bipolar disorder type I was associated with 
ADHD in 18.5% of all cases. The same research shows how ADHD 
affects the clinical picture of SUD, determining an earlier onset (11.4 
years vs. 13.2 years old) and addiction to a larger number of substances 
(3.5 vs 2.9). 
Generally, SUD is more severe in patients affected by ADHD. Carrol e 
Rounsaville have compared subjects who are addicted to cocaine and 
ADHD with subjects who are addicted to cocaine but do not suffer from 
the disorder. The former appeared to be younger at the time of 
observation and treatment, the addiction had an earlier onset, and they 
used larger quantities of the substance more frequently (Carroll e 
Rounsaville, 1993). Similarly, Schubiner et al. (2000) have reported a 
greater number of car accidents and an earlier treatment for SUD in 
adults affected by ADHD compared to subjects without ADHD. 
In an attempt to explain the connection between these two disorders it is 
necessary to take into account that according to a developmental 
prospective ADHD manifests itself before SUD. It is therefore improbable 
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that a SUD could be a risk factor for ADHD. Yet it is not clear to what 
degree ADHD could be considered a precursor of a SUD. In a large 
case-control study (2003), Katusic and colleagues supervised 363 
youths with ADHD from the age of 5 until adolescence, compared and 
paired with 726 check-ups. The obtained results showed that the 
presence of ADHD was associated with a three-fold increase in the risk 
of SUD with an earlier onset of this disorder. From a longitudinal study 
carried out by Molina and Pelham (2003) on 142 adolescents compared 
with 100 checkups, it appears that the severity of the inattentive 
symptoms of ADHD would be linked to the increased risk of SUD. This 
data is significant if the frequent persistency of inattentive symptoms in 
young adults is considered together with the greater risk for the 
development of SUD in this age. 
The presence of ADHD also seems to have an influence on the 
progression of SUD. ADHD and the comorbidities linked to it speed up 
the passage from use of ―soft‖ drugs and alcohol to a ―hard‖ drug 
addiction. Finally, the presence of ADHD seems to compromise the 
prognosis of SUD. Wilens and coll. compared 130 adults affected by 
ADHD and SUD with 71 subjects affected by SUD but without ADHD. 
The remission rate and duration of SUD differed significantly between 
the two groups: SUD had an average duration of three years more and 
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the time required to achieve SUD remission was more than double in 
subjects with ADHD (Wilens, Biederman et al. 1998). 
Assessing the link between ADHD and SUD, familiar studies are 
interesting, as they suggest a common genetic matrix between the two 
disorders. A family aggregation between ADHD in children and SUD in 
first and second degree relatives has been known already for some time 
(Cantwell, 1972). It has emerged from controlled studies that the children 
of subjects affected by SUD are highly affected by ADHD and cognitive 
and behavioural features compatible with the disorder, including a low 
attention capacity, impulsivity, aggressivity and hyperactivity (Stanger et 
al., 1999). 
Judging by the available data, the mechanisms through which the 
presence of ADHD would favour the development of SUD are surely 
numerous, and much remains to be understood. Arias et al. suggest that 
ADHD may be associated with a more severe phenotypic expression of 
SUD because of the presence of higher levels of impulsivity and novelty-
seeking in affected subjects than in those not affected (Arias et al., 
2008). There are some researches that identify the self-medication of 
depressive, anxious and aggressive symptoms as a possible explanation 
of SUD. A recent study by Wilens and colleagues took into account a 
population of subjects affected by ADHD, both adolescents and adults, 
comparing them with a control group in order to understand the 
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motivations behind drug use. Self-medication plays an important role. 
The majority of the subjects used the substance to control their mood, to 
sleep, or without any specific reason. However, there were no 
differences between subjects with ADHD and members of the control 
group, nor have differences been found regarding the choice of a specific 
drug (Wilens et al., 2008). 
 
PREDICTORS OF PERSISTENCE IN ADULTHOOD 
 
Persistence and chronic evolution in adulthood have been reported in 
50-80% of patient suffering ADHD. Comorbidity with other mental 
disorders in childhood is the first predictor of persistence in adulthood, in 
particularly Conduct Disorder, Mood Disorders, Substance Use Disorder 
and their early onset. Obviously a child-adolescent with ADHD and 
comorbid conditions is frequently resistant to treatments, a factor that 
may contribute to the chronic evolution.  
A recent study describes clinical outcomes of youngsters with ADHD 
(Langley K et al, 2010). The study population was composed by 126 
school-aged children (mean age 9.4 years, s.d. = 1.7) that were 
reassessed after 5 years, during the adolescence (mean age 14.5 years, 
s.d. = 1.7), for ADHD, conduct disorder and other antisocial behaviours. 
Most adolescents (69.8%) continued to meet full criteria for ADHD, were 
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known to psychiatric services and exhibited high levels of antisocial 
behaviour, criminal activity and substance use problems. Maternal 
childhood conduct disorder predicted offspring persistence of ADHD; 
maternal childhood conduct disorder, lower child IQ and social class 
predicted offspring conduct disorder. 
Children with attention-deficit/hyperactivity disorder (ADHD) are at risk 
for adverse outcomes such as substance abuse and criminality, 
particularly if they develop conduct problems. Little is known about early 
predictors of the developmental course of conduct problems among 
children with ADHD. Parental psychopathology and parenting were 
assessed in 108 children who first met DSM IV criteria for ADHD at 4-7 
years of age. When demographic variables and baseline ADHD and 
conduct problems were controlled, maternal depression predicted 
conduct problems 2-8 years following the initial assessment, whereas 
positive parenting during the structured parent- child interaction task 
predicted fewer future conduct problems. These findings suggest that 
maternal depression is a risk factor, whereas early positive parenting is a 
protective factor, for the developmental course of conduct problems 
among children with ADHD (Chronis et al, 2007). 
An interesting study (Berlin L et al, 2003) examined whether inhibition 
measured as early as preschool age can predict more general executive 
functioning and ADHD symptoms at school age. In contrast to previous 
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studies, the present study focused specifically on ADHD symptoms 
rather than general disruptive behavior problems, and boys and girls 
were studied separately. The main result was that inhibition was strongly 
related to ADHD symptoms both at school and at home for boys, but only 
in the school context for girls. Early inhibition was also significantly 
related to the development of deficit in executive functions, and a 
positive correlation was found between executive functions and ADHD 
symptoms, although only for boys. The strong relationship between 
inhibition, executive functioning and ADHD symptoms for boys compared 
to girls could suggests that either the predictors of ADHD are different for 
the two sexes, or girls are more often equipped with some factor that 
protects them from developing ADHD symptoms, despite poor executive 
functioning. However, it is also possible that relations are just more 
difficult to be demonstrated for girls than for boys due to their lower 
incidence of disruptive behavioural problems.  
Using data based on self-, parent, and teacher reports, Crystal DS and 
collegues (2001) assessed various aspects of psychopathology in a 
large sample of control children and those with ADHD. Confirmatory 
factor analysis was employed to extract response bias from latent 
constructs of aggression, anxiety, attention problems, depression, 
conduct disorder, and hyperactivity. These latent constructs were then 
entered into logistic regression equations to predict membership in 
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control versus ADHD groups, and to discriminate between ADHD 
subtypes. Results of the regression equations showed that higher levels 
of attention problems and aggression were the best predictors of 
membership in the ADHD group relative to controls. Logistic regression 
also indicated that a higher degree of aggression was the only significant 
predictor of membership in the ADHD-Combined group compared to the 
ADHD-Inattentive group. However, when comorbid diagnoses of 
Oppositional Defiant Disorder and Conduct Disorder were controlled for 
in the logistic regression, greater hyperactivity rather than aggression 
was the sole variable with which to distinguish the ADHD-Combined from 









Co-morbidity among ADHD, SUD and BD has been reported in clinical 
and epidemiological studies. However, few investigations were carried 
out to detect and characterize ADHD in adult patients with SUD and BD 
observed in psychiatric settings. 
For this purpose we evaluated the prevalence of symptoms belonging to 
the ADHD spectrum in two samples of adult patients affected by SUD 
and by BD; we also explored the clinical and epidemiological features 










For this research we have selected a series of 97 consecutive patients 
from out-patient and Day-Hospital services of the Department of 
Psychiatry at University of Pisa in a period of 12 months. The patients 
had a diagnosis of Bipolar Disorder type I or II according to DSM-IV-TR 
criteria. All patients gave their informed consent for the participation and 
the protocol of the study was approved by the ethics committee of Pisa 
University.  
The clinical data was carefully collected through a semi-structured 
interview. For the baseline interview, approximately an hour was needed 
and half an hour for the subsequent visits. The interview was conducted 
by two psychiatrists with at least five years experience in the diagnosis 
and treatment of mood disorders. Each psychiatrist had followed a 
training program for using interviewing tools, which included direct 
observation of experienced interviewers, supervision during the 
interviews and tests of inter-rater reliability. 
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Because data collection depended largely, as far as the anamnestic 
information, on what the patients were able to remember, all the 
information was verified by the project research coordinator in order to 
obtain a consensus agreement with the psychiatrists interviewers . When 
questions arose, patients were contacted for further clarification. In 
almost all cases, the patient medical records were reviewed and missing 
information was gathered from family members or previous health care 
assistants. The following rating tools have been used: ASRS-v 1.1. 
(Adult ADHD Self-Report Scale) and DCTC (Diagnostic, Clinical and 
Therapeutic Checklist). The latter is a semi-structured interview 
developed for the diagnosis of the major clinical syndromes of Axis I and 
II, based on the criteria in DSM-IV for specific nosographic entities. It 
allows systematic demographic, clinical and dialysis information. Patients 
with various origins, were divided almost equally between spontaneously 
referred patients (self-referrals), or on the advice of their physicians or of 
any specialists including psychiatrists. The DCTC allows to evaluate the 
development over timer of psychiatric symptoms using the CGI and 
social adaptation through the GAF and the Sheehan Disability Scale. 
The DCTC also allows to record comorbidity Axis I of the patient and 
possible drug therapies taken. Information on previous treatments and 




For the evaluation of the ADHD, the patients had to fill out the Adult 
ADHD Self-Report Scale (ASRS-v1.1). This self-assessment tool 
consists of 18 items that explore the symptoms presented in the previous 
6 months. The first 6 items allow you to make a diagnostic screening for 
the presence of ADHD in adults. The diagnosis is then prescribed when 
scores reach highs above a predetermined range in more than 4 of the 
first 6 items and that the onset of symptoms is seen before the age of 7 
years old. 
Statistical analysis 
The epidemiological and clinical characteristics were compared between 
two groups: positive diagnosis of Attention Deficit Disorder and 
Hyperactivity Disorder (ADHD) and negative for that diagnosis (non-
ADHD). The comparative analysis for the epidemiological, clinical and 
symptomatic characteristics of the different subgroups was performed 
using one-way-ANOVA for dimensional variables (post-hoc comparisons 
were made using the Bonferroni test) and cross-tabulation for the 
categorical variables. We have used a 2 tail significance levels with a 




         RESULTS 
 
Our sample of 97 patients with Bipolar Disorder I and II is composed of 
58 males (58.9%) and 39 females (40.2%); 19 out of 97 patients (19.6%) 
meet the DSM-IV-TR criteria, scored an appropriate level to the scale 
ASRS to be diagnosed ADHD and reported the onset of ADHD 
symptoms before reaching the age of 7.  
Among subjects diagnosed with ADHD, males are more represented 
(63.2%, n = 12). The average age is 39.7 ± 13.8 for subjects with ADHD 
and 42.6 ± 14.2 for subjects without ADHD. In the group diagnosed with 
ADHD the unmarried prevail (47.4%, n = 9) and the percentage of 
separated or divorced is higher than for the non-ADHD group (21.1%, vs 
7.7%, p = 0.2). While comparing the two groups no significant differences 
emerged with regard to employment, although patients with ADHD were 
found to have lower levels of education. The 47.4% (n = 9) of them 
achieved middle school or lower education level, 42.1% (n = 8) received 
a high school diploma and only 10.5% ( n = 2) holds a BA (Table 3) 
In comparison with the non-ADHD group, patients with ADHD show 
higher rates of depressive episodes (26.3%, n = 5 vs 14.1%, n = 11, p = 
0.2) and manic episodes  (26.3%, n = 5 vs 20.5%, n = 16 ns). None of 
the patients with ADHD was in remission at the time of the recruitment, 
76 
 
while 5.1% (n = 4) of patients in the non-ADHD group were in remission 
(Nieremberg et al., 2005). 
Depressive episodes were significantly more frequent among patients 
with a diagnosis of Bipolar Disorder II and ADHD (42.1%, n = 8 vs 
30.8%, n = 24, p = 0.3).  None of the patients from this group was in 
remission, while in the non-ADHD 2.6% (N = 2) of patients with Bipolar 
Disorder II was in remission (Table 4). 
Patients with ADHD reported significantly higher rate of lifetime 
comorbidity with Substance Use Disorder (SUD) (31.6%, n = 6 vs 17.9%, 
n = 14, p = 0.2). There are also differences in regard to the specific 
abuse such as alcohol (21.1%, n = 4 vs 9%, n = 7, p = 0.1), THC (15.8% 
vs 5.1%, n = 3 , n = 4, p = 0.1), cocaine (15.8%, n = 3 vs. 5.1%, n = 4, p 
= 0.1) (Fischer et al., 2007; Klessler et al. , 2006; Ohlmeier et al., 2007). 
No significant difference is found by comparing the rates of abuse of 
MDMA and heroin (Table 4).  
A significantly higher proportion of patients with ADHD reported 
comorbidity with Impulse Control Disorder (15.8%, n = 3 vs. 3.8%, n = 3, 
p = 0.1) and Generalized Anxiety Disorder (10.5%, n = 2 vs 2.6%, n = 2, 
p = 0.1) (Table 4) (Kessler et al., 2006).  
Patients with ADHD have a higher percentage of Depression (36.8%, n = 
7 vs 17.9%, n = 14), Dysphoric Mania (10, 5%, n = 2 vs 7.7%, n = 6) 
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Mixed State (42.1%, n = 8 vs 29.5%, n = 23). There is also in this group 
a lower percentages of patients in Eutimia (5.3%, n = 1 vs 34.6%, n = 27) 
compared to non-ADHD group. The difference is statistically significant 
with p = 0.1 (Table 5).  
We evaluated the previous response to the antidepressants. Patients 
with ADHD reported higher rates of mood Instability during treatment 
with antidepressants and resistance (Table 5).  
As for global adaptation measured by the Global Assestment of 
Functioning scale (GAF), patients with ADHD reported lower scores 
(47.1 ± 19.5 vs 52.2 ± 24.9). The Shean Disability Scale shows a 
significantly worse functioning behavior in a family adjustment with 
patients with ADHD (5.2 ± 2.4 vs 3.9 ± 2.2, p = 0.04) and no statistical 
difference in ―Social‖ and ―Occupational Functioning‖ (Table 5).  
The CGI-Bipolar show no differences for ―Mania‖, ―Anxiety‖ and 
―Psychosis‖. (Table 5). As expected Patients with ADHD have reported 
significantly higher mean scores in all items and total scores with ASRS 
scale compared to non-ADHD patients (41.6 ± 9.8 vs 23.4 ± 9.4 p = 0.0) 
(Table 6). We have then performed an exploratory factor analysis (Table 
7) of the 18 items of this scale to evaluate how the various items are 
grouped together in our population. The results of the analysis suggest 
that items can be grouped into four factors that explain 56.33% of the 
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variance. In particular, the first factor, which has a Eingenvalue of 2,8 
and explains 15.6% of the variance, can be defined "Hyperactivity / 
Impulsivity"  and comprises the following items:  
 5 (0,586) Shaking hands or feet when the subject has to sit for a long 
time.  
 
 6 (0,633) Feeling overly active or constraint to do something as if driven 
by a motor.  
 
 12 (0,536) Needing to get away from a situation in which one must be 
present.  
 
 13 (0,643)  Feeling non-rested or agitated.  
 
 14 (0,666) Having difficulty to relax  
 
The second factor that has a Eingenvalue of 2,8 and explains 15,6% of 
the variance, can be defined ―inattention‖ and comprises the following 
items:  
 
 4 (0,456) To avoid or delay the execution of a task that requires 
reasoning.  
 
 7 (0,674) Making errors due to distraction while performing a difficult or 
tedious project.  
 
 8 (0,684) Having difficulty to sustain attention during a tedious or 
repetitive job.  
 
 9 (0,636) Having difficulty concentrating on what is being said by the 
interlocutor. 
 







The third factor, "Lack of organization", has a Eingenvalue of 2,6, 
explains 14,3% of the variance, and comprises the following items:  
 
 1 (0,680) Having difficulty in focusing and developing details of any a 
project.  
 
 2 (0,804) Having difficulty in arranging objects while performing a task 
that requires organization. 
 
 3 (0,510) Having trouble remembering appointments and deadlines.  
 
 7 (0,600) Being distracted while performing a difficult and tedious 
project.  
 
 10 (0,456) Loosing things, or having difficulty finding them.  
 
 
The fourth factor that has a Eingenvalue of 1,9 and explains 10,7% of the 
variance,  "Intrusiveness", comprises the following items:  
 
 15 (0,754) Talking too much in social situations.  
 
 16 (0,694) Breaking-off a conversation when the other person has yet to 
finish talking. 
 
 18 (0,584) Interrupt others when they are very busy.  
 
 DISCUSSION 
In our sample of patients with Bipolar Disorder, the prevalence of co-
morbid ADHD is 19,6% (19 vs. 97). This finding is consistent with the 
previous literature (Barkley 2006, Klassen et al., 2010). The ASRS scale 
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used to inquire the ADHD symptoms in adults has been effective in 
identifying those subjects who showed these same symptoms during 
childhood. This enabled the formulation of the ADHD diagnosis in 
adulthood and the comparison of clinical features with bipolar patients 
without ADHD. The persistence of ADHD symptoms seems to negatively 
affect the overall adaptation to adult life, in particular due to the 
interference of the cognitive deficits that tend to have a chronic condition 
influencing the patient‘s relational system(Biederman and Faraone, 
2006). Even in our group with ADHD diagnosis we witnessed this figure, 
in fact the unmarried, the separated and divorced prevailed and the 
same for lower levels of education in respect to the non-ADHD group. 
The clinical condition that requires the simultaneous presence of DB I 
and ADHD is, in our sample, associated with a greater number of 
depressive episodes in health history which reaches statistical 
significance in respect to subjects from the non-ADHD group (26.3%, n = 
5 vs 14.1%, n = 11, p = 0.2). And this is also observed when considering 
patients diagnosed with DB II + ADHD vs the non-ADHD (42.1%, n = 8 
vs 30.8%, n = 24, p = 0.3). None of the patients in group BD + ADHD at 
the time of the visit was in a state of Eutimio, or did not have a state of 
symptomatic remission (Nieremberg et al., 2005). Patients with ADHD 
recorded significantly higher proportion of lifetime comorbidity with 
Substance Use Disorder (SUD) (31.6%, n = 6 vs 17.9%, n = 14, p = 0.2) 
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where in particular those substances were: alcohol, cocaine and 
cannabis also as described by other authors. (Fischer et al., 2007; 
Kessler et al., 2006; Ohlmeier et al., 2007) The only substances that do 
not differ in the two groups studied were Heroin and MDMA. The latter in 
the American studies is frequently associated with ADHD, however in our 
area cocaine is more consumed, due to its spread and the fact that it is 
easily available compared to MDMA. In a recent study conducted in 
Spain (Ferrer et al., 2010) in a group of adult patients with Borderline 
Personality Disorder (BPD) a comorbidity with ADHD of 69% was found, 
and by comparing the BPD + ADHD group in respect to those without 
ADHD, showed a statistically significant greater rate of association with 
substance use disorder (59.4% vs. 38.4%). In addition, the BPD + ADHD 
subjects show a correlation with the aspect "impulsiveness" which is less 
frequent in subjects without ADHD, however characterized by the 
presence of symptoms of mood and anxiety spectrum. Another study 
investigating the presence of ADHD in patients with major depressive 
episodes and  bipolar disorder highlights the frequency of clinical 
observations of ADHD greater in bipolar disorder versus unipolar 
depression (17.6% vs. 5.4%). The DB + ADHD group is associated with 
an earlier onset of disease, a higher number of comorbidities and a 
marked consequent reduction in quality of life. (McIntyre et al. 2010) A 
further research conducted on 211 individuals diagnosed with ADHD 
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emphasizes the association between the severity of symptoms and 
negative events of life regardless of associated comorbidities. (Garcia et 
al., 2010). Patients with coexisting DB, ADHD and SUD present 
inevitably increased severity of the clinical picture in general showing a 
worse prognosis and a poor response to treatment. Until we verify a 
state of abstinence of substances it is difficult to treat ADHD and the DB. 
In particular, the abuse of cocaine and in general the conditions of multi-
drug abuse are less responsive to standard psychopharmacological 
treatment, but once abstinence achieved,  we arrive to the psycho-
affective equilibrium stabilization mainly through the use of mood 
regulators, and finally symptoms of ADHD can be treated. The DB + 
ADHD group also differs to a significantly higher proportion of 
comorbidity with Impulse Control Disorder (15.8%, n = 3 vs. 3.8%, n = 3, 
p = 0.1) and Disorder Generalized Anxiety (10.5%, n = 2 vs 2.6%, n = 2, 
p = 0.1) (Kessler et al., 2006). The course and prognosis of Bipolar 
Disorder is influenced by the association of both ADHD and other 
psychiatric disorders presence. Obviously a medical condition in which 
cognitive and deficit symptoms persist of executive functions leads to 
numerous problems in terms of school/work environment and family 
environment. In fact, Kessler and his colleagues, in a recent study, 
examined the symptoms that most characterize ADHD in adults, 131 
subjects with ADHD compared to 211 controls, observing, through a 
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logistic regression, that the pathognomonic psychopathological item 
appears to be a deficit of executive functions rather than the symptoms 
of inattention. The latter does not represent a distinctive diagnostic 
element as overlapping with other pathological conditions and therefore 
nonspecific (Kessler et al., 2010). Finally, our study describes a 
population of bipolar which, compared by the association with ADHD 
show a more severe psychopathology and a worse level of overall 
functioning compared to non-ADHD group. By documenting the clinical 
impact of ADHD in DB, it is noted that like any comorbidity influences the 
course, the prognosis and especially therapeutic management. If it is 
better to limit the use of antidepressants in the DB, in the event of 
comorbidity DB + ADHD, scrutiny must be greater. In our sample we 
observed the mood instability and irritability appearance after taking 
psychotropic medication therapy based mainly on serotonergic 
antidepressants (SSRI) in both groups. However, there are some 
patients with DB and DB + ADHD that are getting a clinical efficacy from 
such treatment. They are the subjects who, for the most part, have 
anxiety disorder in combination, such as Panic Disorder and Generalized 
Anxiety Disorder. Or subjects who maintain a good psycho-affective 
balance by following an appropriate stabilizing therapy with lithium salts 
and / or antiepileptic, which doe not undergo through hypo / mania 
changes during treatment with SSRI or with other antidepressants. More 
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scientific researches are needed to explore these therapeutic 











A sample of 109 consecutive out-patients with Substance Use Disorder 
was selected among the outpatiens attending the Ser.T. (literally 
―Servizio per le Tossicodipendenze‖) of Viareggio (LU) and the outpatient 
Services of ―Incontro‖ and ―Ce.I.S.‖ Therapeutic Community, based in 
Pistoia and Livorno respectively, over a period of about 12 months. 
Informed consent was provided by all patients, and the study protocol 
was approved by the Ethic Committee of the University of Pisa. 
Clinical data were collected by means of an in-depth semi-structured 
interview; the basal evaluation lasted 1 hour approximately. The 
interviews were conducted by two specialists with minimum 5 years 
experience in dealing with diagnosis and treatment of Affective and 
Substance Use Disorders.  
The methodology of evaluation and the instrument utilized were the 





Epidemiological and Clinical characteristics as well as ADHD 
symptomatology detected by means of ASRS were compared in the two 
groups of patients: those with (ADHD) and without (no-ADHD) a 
diagnosis of ADHD. Comparative analysis for epidemiological, clinical 
and symptomatological characteristics of the different subgroups was 
accomplished using logistic regression analysis and cross-tabulation for 
categorical variables. The significance level chosen was p <0.5  (two-
tailed). Exploratory Factor analysis for ASRS items was conducted using 




Among the 109 patients affected by SUD (81 males and 28 females), 20  
(18,35%) report a diagnosis of ADHD according to DSMIV and ASRS-
v1.1. No difference can be observed between ADHD and no-ADHD 
patients as regards age, sex, marital status, employment and education. 
(Table 8). The two groups do not show differences for substances in use 
as well (Table 9), even though in the no-ADHD group the share of 
cannabis-abusers is higher (27%vs10%). As regards lifetime psychiatric 
comorbidity (Table 9), ADHD patients show larger prevalence of Bipolar 
Disorder (80% vs 43.2%, OR 8.84, p.003) and current manic of mixed 
episode at the time of observation (40% vs 16.9%, OR 3.29, p=.027). No 
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significant difference between ADHD and No-ADHD patients has been 
observed in terms of prevalence of comorbid Anxiety Disorders and 
Impulses Control Disorders. As expected, the CGI-bipolar scores (Table 
9) reported by ADHD patients were generally higher for items such as 
―Mania‖ (0.95, ds=1.43 vs 0.52, ds=0.91; OR 1.42, p=.097) and ―Mixed 
Simptoms‖ (1.40, ds=2.01 vs 0.69, ds=1.42; OR 1.23, p=.071), the 
differences ar not statistically significant. 
 ADHD patients did not differ from No-ADHD patiens as regards social, 
familial or professional adjustment, as measured by Sheehan Disability 
Scale and GAF (Table 9).  
As concern the response to previous antidepressant treatment (Table 
10): no significant differences can be observed in ―manic switch‖ and 
―mood instability‖, but ADHD patients report more frequently ―resistance 
to treatment‖ (15% vs 3.4%, chi-square 4.25, p=.039) and ―irritability‖ 
hi-square 3.90, p=.048).  
As expected, the ASRS score calculated with 6 items (15.05, ds=3.2 vs 
7.38, ds=3.50 ; OR 8.99, p=.000) and with 18 items (41.2, ds=6.75 vs 
24.46, ds=9.35; OR 7.56, p=.000) was significantly higher in ADHD 
patients. In addition all ASRS items discriminates between the two 
diagnostic groups, with OR values ranging from 7.44 for item 4 to 1.52 
for item 10.  
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The factor analysis (Table 11) of the ASRS 18 items indicates a 3 factor 
solution, accounting for 47,73% of the total variance. The first factor, 
―Attention deficit‖, with an Eingenvalue of 3.2, account for 17.9% of the 
total variance, and encompasses items 3 -Having trouble remembering 
appointments and deadlines- (.451), 4 (.590), 5 (.406), 7 (.722), 8 (.682), 9 
(.534), 10 (.715), 11 (.473), 12 (.484). The second factor, ―Hyperactivity-
Impulsivity‖, with an Eingenvalue of 2.8, account for 15.5% of the 
variance, and comprised the items 5 - Shaking hands or feet when the subject 
has to sit for a long time- (576), 6 (.429), 11 (.501), 15 (.695), 16 (.771), 17 
(.415), 18 (.570). The third factor, ―Disorganization‖, with an Eigenvalue 
of 2.6, account for 14.3% of the variance and comprised the items 1- 
Having difficulty in focusing and developing details of any a project- (.722), 2 




In our sample of 109 patients with SUD, 18 %  present a diagnosis of 
adult ADHD. This finding is consistent with other studies: the prevalence 
of ADHD in SUD patients is about three times higher than in general 
population (Levin 1998), (King, Brooner et al. 1999), (Clure, Brady et al. 
1999). On the other hand, the rate of SUD in ADHD patients can reach 
up to 40% (Kalbag and Levin 2005), substantially higher than what is 
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observed in general population (about 14,6% - Kessler, Adler et al. 
2005). Some authors report that ADHD diagnosis is associated with early 
onset and severe course of SUD, with increased number of relapses and 
longer time elapsed for remission (Carroll and Rounsaville 1993), (Wise, 
Cuffe et al. 2001), (Stein, Marx et al. 2004) , (Wilens, Biederman et al. 
1997). In recent study by Arias et al. (Arias, Gelernter et al. 2008), a 
sample of 1761 SUD patients was studied and the results showed 
generally larger use of substances in probands with ADHD. In our study 
no difference could be detected bewteen the ADHD  and the no-ADHD 
group, partly on account of the limited numerosity of our sample, but 
probably also because of the type of abuser patients, who were mostly 
opioid addicts with high rates of polyabuse. For the same reason, no 
statistical differences have been observed in the analysis of socio-
demographic variables. Some authors have suggested that patients with 
ADHD may use stimulants such as cocaine, to reduce symptoms typical 
of their disorder, however no significant difference in the type of 
substance used in SUD patients with and without ADHD is detected 
either in our sample or in other studies available in current literature 
(Biederman, Wilens et al. 1995). 
In absence of convincing evidence addressing the issue of self-
medication, it is more reasonable to propose that the use of substances 
in ADHD patients is facilitated by impulsivity typical of their disorder 
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(Arias, Gelernter et al. 2008) and by the increased presence of 
comorbidity for mood disorders. The analysis of comorbid psychiatric 
disorders shows that the Bipolar Disorder (BD) is more common in the 
ADHD group compared to the no-ADHD: as much as 80% of patients 
with ADHD had a Bipolar Disorder. A greater rate of BD in patients with 
ADHD and SUD compared to no-ADHD SUD has also been reported by 
Arias et al. (Arias, Gelernter et al. 2008) but with lower prevalence 
(5.25% for Bipolar Disorder type I, vs 65% in the sample in question). 
This difference may be largely accounted for the different methodological 
procedures, setting recruitment, numerosity and severity of the selected 
patients. The same authors reported a higher frequency of conduct 
disorder and antisocial personality disorder, but these diagnosis were not 
investigated in our study, and post-traumatic stress disorder, which we 
did not detect most probably due to limited sample size. 
 Patients with ADHD report high rates of a positive family history for BD 
(Dilsaver, Henderson-Fuller et al. 2003); (Secnik, Swensen et al. 2005). 
On the other hand ADHD is often diagnosed in patients with Bipolar 
Disorder (Tamam, Karakus et al. 2008), (Sentissi, Navarro et al. 2008); 
(Tamam, et Tuglu al. 2006); (Sachs, Baldassano et al. 2000). The 
comorbidity for ADHD is particularly high in pediatric samples, reaching 
38 - 98% (Tamam, Karakus et al. 2008); (Sachs, Baldassano et al. 
2000), and decreases in adult population up to 9-35% (Tamam, Karakus 
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et al. 2008); (Nierenberg, Miyahara et al. 2005), (Sentissi, Navarro et al. 
2008); (Tamam, Tuglu et al. 2006). In this study, subjects with BD and 
ADHD appear to have worse course than no-ADHD, they have a higher 
rate of manic or mixed episodes at the time of observation with a 
generally greater severity (although this finding does not reach the 
statistical significance).  
In current literature there are no studies that compare abuser bipolar 
patients with and without comorbid ADHD, but it is well known that, in 
general, BD individuals with ADHD have a worse course of illness than 
non-ADHD BD individuals: the onset of manic symptoms is early (Kent 
and Craddock 2003), (Wingo and Ghaemi, 2007); (Nierenberg, Miyahara 
et al. 2005); (Masi et al. 2006); (Sachs, Baldassano et al. 2000), 
(Jaideep et al., 2006), possibly as earlier as 3-5 years (Nierenberg et al. 
2005); (Masi et al., 2006). In addition there is a worse course (Wingo and 
Ghaemi, 2007); (Nierenberg, Miyahara et al. 2005); (Tamam, Tuglu et al. 
2006), higher rates of bipolar disorder type I (Nierenberg, Miyahara et al. 
2005), a higher frequency of depressive episodes (Tamam, Tuglu et al. 
2006) and manic episodes (Nierenberg, Miyahara et al. 2005), with 
shorter intervals free from disease (Nierenberg, Miyahara et al. 2005). 
This has led to the hypothesis that bipolar disorder comorbid with ADHD 
is actually a distinct phenotype (Faraone, Biederman et al. 1997). 
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Familiarity studies seem to confirm this hypothesis. (Faraone and 
Biederman 1994); (Wozniak, Biederman et al. 1995). 
Finally, we investigated the response to antidepressants in the studied 
sample, and patients with ADHD have greater resistance to treatment 
and irritability compared with No-ADHD subjects. In literature it is 
reported that patients with ADHD and substance abuse may benefit from 
treatments based on bupropion, with improvement of both ADHD 
symptoms and craving for substances (Riggs, Leon et al. 1998); (Wilens, 
Spencer et al. 2001), (Levin, Evans et al. 2002); (Wilens, Prince et al. 
2003), other studies show positive response to methylphenidate (Levin, 
Evans et al. 1998). 
In the present study a distinction was not made as regarded response to 
different antidepressants, but most of the subjects had taken SSRIs. The 
data in our possession may suggest a poorer response to SSRI 
antidepressants in patients with SUD and ADHD, but the findings may be 
due the higher rate of individuals affected by BD in SUD patients with 
ADHD. Further researches with larger samples are in order to clarify this 
aspect. 
Factor analysis of the ASRS scale suggests that, in a population of 
patients with substance abuse, those items that explore symptoms of 
ADHD are mainly distributed in three groups: disattention, hyperactivity-
impulsivity and disorganization. The factor of attention deficit is the most 
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important in our series of adult patients with SUD; this finding is 
consistent with findings from other studies (Heiligenstein, Conyers et al. 
1998), (Fischer, Barkley et al. 2007); (Barkley, Fischer et al. 2006), 
according to which the attention deficit component keeps stable and is 
maintained through the years, while the hyperactivity tends to decrease. 
In our patients, hyperactivity and impulsiveness are associated in a 
unique factor that has a similar weight to the disorganization factor. In 
the adult with SUD, difficulties with attention and organization seem to 
take a particular significance constituting an essential part of the 
simptomatologic picture. These results can also be explained, at least in 
part, with cognitive impairment related to chronic use of psychotropic 
substances. Another possibility is that the severity of inattention is the 
variable that best correlates with an increased risk for developing SUD in 
individuals with ADHD, as already supported by other authors (Molina 







Comorbid ADHD in a clinical sample of patients with Sustance Use 




A sample of 147 consecutive patients was selected among the 
outpatients attending the Day Hospital and Ambulatory Unit of the Clinica 
Psichiatrica, University of Pisa, the inpatients and outpatiens attending 
the Hospital and Ambulatory Service of Psichiatry in Ospedale della 
Versilia and Ser.T. Ambulatory (literally ―Servizio per le 
Tossicodipendenze‖, that is Service for Addiction Disorders) in Viareggio 
and the Ambulatory of ―Incontro‖, a Therapeutic Community based in 
Pistoria, over a period of about 12 months. 
According to DSM-IV-TR [1] criteria by means of SCID-I [2], 50 patients 
were diagnosed Bipolar Disorder type I or II (BIP) and 53 were 
diagnosed Substance Use Disorder, while 44 were Dual Diagnosis 
patients. 
Informed consent was provided by all patients, and the study protocol 
has been approved by the Ethic Committee of University of Pisa. 
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The methodology and the evaluation instruments utilized for the present 
study were the same described in the Study 1. 
 
Statistical Analysis 
Epidemiological and Clinical characteristics as well as ADHD 
symptomatology detected by means of ASRS were compared in the 
three groups of patients: SUD (n=53), BIP (n=50), SUD+BIP (n=44). 
Comparative analysis for epidemiological, clinical and symptomatological 
characteristics of the three subgroups was accomplished using one-way 
ANOVA for dimensional variables (Bonferroni test was implemented as 
well for post-hoc comparisons) and cross-tabulation for categorial 




Our sample of 147 patients consisted of 95 males (64.6%) and 52 
females (43.4%). (Table 12). Individuals belonging to BIP subgroup 
showed highest mean age (42.9+15.0) while SUD showed the lowest 
(24.8+9.6).  Subgroup SUD+BIP showed a mean age of 34.9+6.8, an 
intermediate value between the other 2 subgroups. As regards sex 
distribition, the BIP subgroup included fewer males in comparison to 
SUD and SUD+BIP (46%, 71.7% and 77.3% respectively). SUD and 
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SUD+BIP patients included mostly unmarried individuals whilst the BIP 
subgroup had a larger number of married patients. No differences were 
shown regarding employment, whereas education level was lower in 
SUD+BIP. 
As regards the diagnostic profile at the time of observation (Table 13), 
the BIP subgroup included more patients in current manic episode or 
remission, while SUD+BIP patients presented a higher number of mixed 
episodes, even though this difference did not reach statistical 
significance. Prevalence of Bipolar Depression was similar in BIP and 
SUD+BIP subgroups. 
Diagnosis of Alcohol Abuse was more frequent in SUD patients whilst 
SUD+BIP patients presented Cocaine Use Disorder more frequently, 
both  differences did not reach statistical significance though; Heroin 
Addiction was similarly represented in SUD and SUD+BIP (30.2% vs 
36.4%).  
Most patients presented at least one concomitant mental disorder. 
Specifically, SUD+BIP patients showed higher ratios of comorbidity than 
the other two groups, reaching statistic significance for prevalence of 
Cocaine and stimulants, Alcohol Use and Substances polyabuse.  
GAF scores indicated a better general functioning in SUD patients 
(61.8+20) while BIP and SUD+BIP patients obtained lower scores 
(52.4+22.4 vs 55.7+12.2 respectively). Social Adaptation as measured 
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by means of Sheehan Disability Scale in the three functional areas of 
work, family and social relationships did not show statistically significant 
differences in the three groups, indicating moderately impaired levels of 
adaptation in all patients. 
From a psychopathological perspective, the global clinical evaluation of 
severity (obtained through the CGI) showed higher scores in BIP and  
SUD+BIP in comparison to SUD patients for depression, mixed state and 
psycosis. The BIP group showed higher scores in mania scale and lower 
scores in the impulsivity scale in comparison to the other two groups. 
 23 patients (15.6%) reported diagnostic scores in ASRS accompanied 
by a history of ADHD in childhood, thus permitting a diagnosis of Adult 
ADHD. An additional 24 patients (16.3%) showed high scores but did not 
report a history of ADHD in childhood. 
From the comparison among the 3 groups (Figure 1) 13 (29.5%) patients 
with SUD+BIP reported a history of ADHD in contrast with only 4 (7.5%) 
SUD and 6 (12%) BIP patients. The difference was statistically 
significant. 
Most items (15 over 18) of ASRS (Table 14) did not show significant 
difference between the 3 subgroups even though SUD+BIP patients 
reported higher mean scores in all explored variables. Only three items 
showed significant difference: Item 2, ―difficulty getting things in order 
when you have to do a task that requires organization‖ and Item 17, 
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―difficulty waiting your turn in situations when turn taking is required‖ 
show significantly higher scores in SUD+BIP patients in comparison to 
the other 2 groups. Item 14, ―difficulty unwinding and relaxing when you 
have time to yourself‖, differentiates BIP and BIP+SUD from SUD. 
As regards the total score of the first 6 Items, the most important in terms 
of diagnostic specificity, SUD+BIP showed higher scores than the other 2 




Our sample of 147 patients with Bipolar Disorder, Substance Use 
Disorder or Dual Diagnosis present ADHD comorbidity in about 15% of 
the cases; an analogous ratio of patients reports high scores in ASRS 
but does not report onset in childhood as required for diagnosis. 
The rate of comorbidity observed in our study is consistent with those 
reported by other authors (Kessler et coll., 2006) with different diagnostic 
instruments on similar samples. 
Comorbidity with ADHD is found in about a quarter of Dual Diagnosis 
(SUD+BIP) patients, this represents a rate higher than those found in 
patients with either SUD or BIP disorder alone. This finding is consistent 
with the results of other studies (Tamam L. e coll., 2008). 
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As regards demographic variables, the subgroups with SUD included a 
preponderance of unmarried individuals, while Bipolar patients were 
more frequently married. This finding is compatible with the different 
mean ages in the three subgroups, with BIP patients being older than the 
others. 
The three groups showed no difference regarding employment, whilst 
education was significantly poorer in SUD+BIP. This result is coherent 
with the impaired school performance associated to a history of ADHD in 
childhood. Other authors (Barkley, 2008) reported poor levels of 
education in adult ADHD patients. 
As regards diagnosis, patients did not differ for the specific substance 
used, even though alcohol was more frequent in SUD patients whereas 
Cocaine Use Disorder prevailed in SUD+BIP. 
As expected, most patients presented at least one psichiatric 
comorbidity. In SUD+BIP patients, for instance, high rates of comorbidity 
were reported. Cocaine and stimulants use, Alcohol Use and Polyabuse 
characterized  Dual Diagnosis patients. 
This finding is in line with previous observations (Levin F.R., 2007; 
Tamam L. e coll., 2008) implying that the associations with ADHD and 
Mood Disorders seem to identify a specific SUD subgroup whose 




As regards the symptom profile at time of observation, BIP patients more 
frequently presented a current manic episode or remission, while 
SUD+BIP reported a larger number of mixed episodes. The global 
clinical assessment of severity showed larger presence od Depressive, 
Mixed and Psychotic symptoms in BIP and SUD+BIP patientes. As 
expected from diagnosis, BIP patients reported more severe manic 
symptoms and lower levels of impulsivity in comparison to both the other 
two groups. 
The association between Mixed symptoms, SUD+BIP and ADHD bears 
remarkable clinical interest and important implications from a therapeutic 
point of view. 
As regards ADHD specific symptomatology, Dual Diagnosis patients 
reported high scores in all the explored areas and more commonly 
reported ― difficulty getting things in order when you have to do a task 
that requires organization‖ and ―difficulty waiting your turn in situations 
when turn taking is required‖. Both items required for diagnosis and total 
ASRS score suggested an increased severity of various aspects of 
ADHD such as lack of attention, impulsivity and difficulty in organization. 
―Difficulty unwinding and relaxing‖ was more frequently associated to 






Our research has some methodological limitations that need be taken 
into account for the interpretation of the results. The data collection is 
retrospective and recollection bias can affect the diagnosis and onset of 
symptomatology. However, this bias is shared by all three groups in 
study. Moreover, the retrospective diagnosis of ADHD is probably 
underepresented, as it is scarcely identified and reported in our country. 
More importantly, our sample shows substantial heterogeneity in terms 
of sex, age and provenance, as this concerns the interpretation of our 
results. For instance, the differences in age and sex could affect the 
relative prevalence of ADHD. Our BIP patients present higher mean age 
and are more frequently female, therefore the prevalence of ADHD might 
be lower if compared to a sample matched for demographic 
characteristics. By contrast, Substance Use is very common in young 
male bipolar patients. 
In addition, patients were recruited from Ser.T, communities and tertiary 
care centers, therefore the observations are related to a sample with 
remarkably serious psychopathology, not necessarily representative of 
patients with SUD belonging to the general population. Another limitation 
is related to the fact that, since the study was accomplished by expert 
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clinical evaluators, they were not blind with respect to the diagnosis. The 









The persistence of ADHD in adulthood is a complex underdiagnosed 
clinical condition. In most adult patients, ADHD is associated with 
another mental disorder and can be concealed by its presence; 
comorbidity will affect clinical presentation, severity, natural course, 
prognosis and treatment.  
Substance Use Disorders and Mood Disorders are frequently associated 
with Adult ADHD. Our patients with BD and ADHD appear to have a 
worse course with a large number of manic or mixed episodes at the 
time of observation and greater severity of sintoms. Our results are 
consistent with those obtained from a study of Bernardi and colleagues 
on a sample of 100 patients aged between 18 and 30 years with a 
diagnosis of Bipolar Disorder in remission. The study shows that 18% of 
patients present lifetime and 10% current comorbidity of ADHD + BD and 
that this event is characterized by an earlier onset of mood disorder, a 
greater number of affective episodes and greater impulsivity compared to 
bipolar patients without ADHD. This findings suggest the possibility that 
patients with bipolar disorder who have a diagnosis of ADHD in 
adulthood represent a clinically distinct phenotype (Bernardi et al., 2010). 
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Similarly, we found that one fifth of our sample of bipolar adults has a 
current diagnosis of ADHD, and that these patients are characterized by 
a greater number and more severe depressive episodes, resulting in a 
marked interference in global adaptation, when compared with ADHD 
subjects without bipolar. To complicate the clinical picture in BD + ADHD 
group, they are often associated with the Substance Use Disorder and 
the Impulse Control Disorder.  
The STUDY 2 indicate high prevalence of symptoms of ADHD in an adult 
population with Substance Use Disorder: about 1 patient in 5 reported 
symptoms compatible with a diagnosis of ADHD. In our sample, there 
are no differences between groups with and without ADHD in the type of 
substance used, partly because of the limited sample size, but probably 
also for the type of patients, predominantly opioid-dependent and 
burdened by a high rate of poli-drug abuse. Patients with ADHD, 
compared with patients with substance abuse without ADHD, reported  
more frequent comorbid BD and history of resistance or irritability in 
response to antidepressants.  
Factor analysis of the ASRS scale, in patients with substance abuse, 
reveals that symptoms of ADHD are distributed in three main 
dimensions: inattention, hyperactivity-impulsivity and disorganization.The 
Inattention is the most important factor, while hyperactivity and 
impulsivity are associated in a single factor that has a weight similar to 
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the disorganization factor. Inattention and difficulties in organization 
therefore seem to assume a significant importance in SUD, being an 
essential part of the symptomatological picture.  
Substance Use Disorder is widespread in general population (Kandel e 
coll., 1997) and a remarkable part of these individuals shows symptoms 
of ADHD (Wilens, 2004). On the other hand, ADHD is a risk factor for 
Substance Use in itself.  
In STUDY 3, 1 Dual Diagnosis patient out of 4 reported childhood history 
of ADHD and more than 1 patient out of 2 presented corresponding 
symptoms at the time of observation. Our data are consistent with the 
observation that SUD in ADHD patients features an earlier onset, a 
longer duration and a faster progression towards substance polyabuse 
(Wilens 1998, 2003). In addition, the risk for developing a SUD is 
increased by the comorbidity of ADHD and Bipolar Disorder. 
Differential diagnosis between ADHD and Bipolar Diroder is hardly 
manageable for the substantial symptomatologic overlap between the 
two conditions. Prolonged hypomania, especially in teenagers and young 
adults, is not easily distinguished from hyperactivity and impulsivity 
observed in ADHD, and many cases may be affected by both conditions 
concomitantly. The comorbidity also seems to increase the risk to 
develop SUD dramatically. 
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Our study confirms the observation that the relationship between adult 
ADHD and Substance Use Disorder is conveyed by the association with 
conduct disorders and antisocial personality disorder. Our data are 
consistent with the hypothesis that this relationship may also be 
facilitated by the presence of Bipolar Disorder. In conclusion, Bipolar 
Disorder, ADHD, Conduct Disorder and Substance Use Disorder may 
share a common diathesis conveyed by hyperactivity-impulsivity. 
Further prospective studies are needed to confirm our observations and 
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TABLE 1  (DSM –IV TR Criteria ADHD) 
 
A. Either (1) or (2): 
 
(1) Six (or more) of the following symptoms of inattention have 
persisted for at least 6 months to a degree that is maladaptive and 




(a) often fails to give close attention to details or makes careless 
mistakes in schoolwork, work, or other activities 
(b) often has difficulty sustaining attention in tasks or play 
activities 
(c) often does not have seem to listen when spoken to directly 
(d) often does not follow through on instructions and fails to 
finish schoolwork, chores, or duties in the workplace (not 
due to oppositional behavior or failure to understand 
instructions) 
(e) often has difficulty organizing tasks and activities 
(f) often avoids, dislikes, or is reluctant to engage in tasks that 
require sustained mental effort (such as schoolwork or 
homework) 
(g) often loses things necessary for tasks or activities (e.g., toys, 
school assignments, pencils, books, or tools) 
(h) is often easily distracted by extraneous stimuli 
(i) is often forgetful in daily activities 
(2) six (or more) of the following symptoms of hyperactivityimpulsivity 
have been persistent for at least 6 months to a degree that 




(a) often fidgets with hands or feet or squirms in seat 
(b) often leaves seat in classroom or other situations in which 
remaining seated is expected 
(c) often runs about or climbs excessively in situations it is 
inappropriate (in adolescents or adults, may be limited to 
subjective feelings of restlessness 
Diagnostic Criteria For ADHD – DSM-IV-TR 
Provided By ADHDFamilyOnline.com Reference: (APA [DSM-IV-TR] 2000) 
(d) often has difficulty playing or engaging in leisure activities 
quietly 
(e) is often ―on the go‖ or often acts as if ―driven by a motor‖ 
(f) often talks excessively 
Impulsivity: 
(g) often blurts out answers before questions have been 
completed 
(h) often has difficulty awaiting turn 
(i) often interrupts or intrudes on others (e.g., butts into 
conversations or games) 
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B. Some hyperactive-impulsive or inattentive symptoms that caused 
impairments were present before age 7 years. 
 
C. Some impairment from the symptoms is present in two or more 
settings (e.g., at school [or work] and at home). 
 
D. There must be clear evidence of clinical significant impairment in 
social, academic, or occupational functioning. 
 
E. The symptoms do not occur exclusively during the course of a 
Pervasive Developmental Disorder, Schizophrenia, or other Psychotic 
Disorder and are not better accounted for by another mental disorder 
(e.g., Mood Disorder, Anxiety Disorder, Dissociative Disorder, or a 
Personality Disorder). 
 
Code Based On Type: 
 
314.01 Attention-Deficit/Hyperactivity Disorder, Combined Type: 
if both Criteria A1 and A2 are met for the past 6 months 
314.00 Attention-Deficit/Hyperactivity Disorder, Predominantly 
Inattentive Type: 
if Criterion A1 is met but Criterion A2 is not met for the past 6 months 
314.01 Attention-Deficit/Hyperactivity Disorder, Predominantly 




Table 2. Utah Criteria for Adult Attention-Deficit/Hyperactivity Disorder 
 
I. Diagnosis retrospective of ADHD in childhood 
           A. Interview to parents (DSM-IV criteria) 
           B. Interview to patient, to find these symptoms 1-2: 
                                      1) Hyperactivity in childhood  
                                      2) Disattention in childhood 





No tollerance to stress 
Disorganization 
Impulsivity 
III. No for depression, psychosis and personalty disorder. 
 
A Parent Rating Scale of Childhood Behaviour 
B Wender Utah Rating Scale self-report 
 
Table 3. Demographic aspects in patient affected by Bipolar Disorder with or 
without ADHD. 
 ADHD 
N = 19 
No – ADHD 
N = 78 
t or  2 p 
Age, mean (sd) 39,7 (13,8) 42,6 (14,2) .786 .434 
Gender: male, n (%) 12 (63,2) 46 (59) .11 .739 
     
Civil status, n (%)     
Unmarried 9 (47,4) 32 (41)   
Married  5 (26,3) 38 (48,7)   
Separated / Divorced 4 (21,1) 6 (7,7)   
Widow 1(5,3) 2(2,6) 4,9 .181 
     
Education, n (%)     
University 2 (10,5) 10 (12,8)   
High school 8 (42,1) 33 (42,3)   
Low school 9 (47,4) 34 (43,6) .4 .949 
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Table 4. Diagnostic aspects in patient affected by Bipolar Disorder with or without 
ADHD. 
 ADHD 
N = 19 
No – ADHD 
N = 78 
t or  2 P 
Psychiatric Diagnosis, n (%) 
Bipolar Disorder I 
Depressive Episode 
5 (26,3) 11 (14,1) 1,7 .198 
Bipolar Disorder I 
Mixed State 
5 (26,3) 25 (32,1) 0,2 .628 
Bipolar Disorder I 
Manic 
5 (26,3) 16 (20,5) 0,3 .582 
Bipolar Disorder I 
Remission 
-- 4  (5,1) 1 .313 
Bipolar Disorder II 
Depressive Episode 
8 (42,1) 24 (30,8) 0,9 .346 
Bipolar Disorder II 
Remission 
-- 2 (2,6) 0,5 .481 
Congruent psychotic 
characteristic  




2 (10,5) 4 (5,1) 0,8 .381 
Alcol 4 (21,1) 7 (9) 2 .137 
MDMA 1 (5,3) 4 (5,1) 0,01 .981 
THC 3 (15,8) 4 (5,1) 2,6 .107 
Heroin 1 (5,3) 4 (5,1) 0,01 .981 
Cocaine 3 (15,8) 4 (5,1) 2,6 .107 
SUD 6(31,6) 14(17,9) 1,7 .188 
Panic Disorder 6 (31,6) 22 (28,2) 0,1 .771 
Social Phobia -- 4 (5,1) 1 .313 
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OCD 1 (5,3) 5 (6,4) 0,04 .852 
GAD 2 (10,5) 2 (2,6) 2,5 .118 
Bulimia -- 1 (1,3) 0,2 .620 
Impulse Control 
Disorder  




Table 5. Clinical aspects in patient affected by Bipolar Disorder with or without 
ADHD. 
 ADHD 
N = 19 
No – ADHD 
N = 78 
t or  2 p 
Current Mood, n (%) 
Depression 7 (36,8) 14 (17,9)   
Euthymia 1 (5,3) 27 (34,6)   
Disphoric Mania 2 (10,5) 6 (7,7)   
Euphoric Mania  1 (5,3) 6 (7,7)   
Mixed State 8 (42,1) 23 (29,5) 8,6 .126 
     
Pregress response to antidepressant, n (%) 
Swicth ipo/manic 3 (15,8) 17 (21,8) 0,3 .562 
Mood Instability  5 (26,3) 18 (23,1) 0,9 .766 
Resistence to treatment 4 (21,1) 12 (15,4) 0,4 .551 
Irritability 4 (21,1) 22 (28,2) 0,4 .528 
     
GAF, mean (ds) 47,1 
(19,5) 
52,2 (24,9) - 0,8 .410 
     
Sheehan Disability Scale, mean (sd): 
School/work 5,7 (2,5) 4,6 (2,6) 1,7 .095 
Social 5,8 (2,4) 4,8 (2,5) 1,7 .089 
Family 5,2 (2,4) 3,9 (2,2) 2,1 .040 
     
CGI- Bip, mean (sd) 
Manic Severity 1,9 (1,9) 1,6 (1,6) 0,8 .422 
Depressive Severity 2,5 (1,3) 2,1 (1,5) 1,0 .316 
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Mixed Severity 1,4 (1,3) 1,6 (1,7) - 0,5 .641 
Anxious Severity 2,4 (1,9) 1,9 (1,6) 1,0 .318 
Hympulsivity Severity 1,7 (1,7) 1,3 (1,5) 1,1 .264 




Table 6.  ASRS scores comparison in patient affected by Bipolar Disorder with or 
without ADHD. 
 ADHD 
N = 19 
No – 
ADHD 
N = 78 
f or  2 p 
Items, mean (sd) 
1- Having difficulty in focusing and 
developing details of any a project. 
2,5 (0,9) 1,1 (1,1) 5,2 .000 
2- Having difficulty in arranging 
objects while performing a task 
that requires organization. 
2,6 (1,1) 0,9 (1,0) 6,4 .000 
3- Having trouble remembering 
appointments and deadlines  
2,5 (1,2) 1,1 (1,2) 4,6 .000 
4- To avoid or delay the execution 
of a task that requires reasoning. 
3,1 (0,8) 1,2 (1,0) 7,4 .000 
5- Shaking hands or feet when the 
subject has to sit for a long time.  
3,0 (1,3) 1,3 (1,2) 5,7 .000 
6- Feeling overly active or 
constraint to do something as if 
driven by a motor.  
2,4 (1,4) 1,0 (1,3) 4,1 .000 
7- Making errors due to distraction 
while performing a difficult or 
tedious project. 
2,6 (0,8) 1,4 (1,0) 4,9 .000 
8- Having difficulty to sustain 
attention during a tedious or 
repetitive job. 
2,6 (1,1) 1,6 (1.1) 3,7 .000 
9- Having difficulty concentrating 
on what is being said by the 
interlocutor. 
2,5 (1,0) 1,3 (1,1) 4,5 .000 
10- Loosing things, or having 
difficulty finding them. 
2,5 (1.3) 1,5 (1,1) 3,2 .002 
11- Being distract from surround 
environment: noises and activities. 
2,1 (1,1) 1,5 (1,0) 2,2 .030 
12- Needing to get away from a 
situation in which one must be 




13- Feeling non-rested or agitated. 2,7 (1,0) 2,1 (1,1) 2,3 .026 
14- Having difficulty to relax 2,2 (1,3) 1,5 (1,1) 2,6 .011 
15- Talking too much in social 
situations. 
1,7 (1,3) 1,5 (1,3) .826 
 
.411 
16- Breaking-off a conversation 
when the other person has yet to 
finish talking. 
2,1 (0,9) 1,3 (1,1) 2,5 .016 
17-Difficulty to wait your turn 1,4 (1,3) 1,2 (1,2) .671 .504 
18- Interrupt others when they are 
very busy. 
1,3 (1,1) 1,0 (1,0) 1,1 .278 
Score 
Total, mean (sd) 





Table 7. Factor analisys of ASRS items in 97 patients with Bipolar Disorder  
Item ASRS Factor 1  
Hyperactivity/ 
Hympulsivity 
Factor 2  
Inattention 





1- Having difficulty in focusing 
and developing details of any 
a project. 
.078 .205 .680 - .008 
2- Having difficulty in 
arranging objects while 
performing a task that 
requires organization. 
.118 .201 .804 .218 
3- Having trouble 
remembering appointments 
and deadlines 
.317 .381 .510 - .225 
4- To avoid or delay the 
execution of a task that 
requires reasoning. 
.375 .456 .254 .252 
5- Shaking hands or feet 
when the subject has to sit for 
a long time.  
.586 .277 -.024 .069 
6- Feeling overly active or 
constraint to do something as 
if driven by a motor 
.633 - .127 .174 .360 
7- Making errors due to 
distraction while performing a 
difficult or tedious project. 
.073 .674 .600 .077 
8- Having difficulty to sustain 
attention during a tedious or 
repetitive job. 
.069 .684 .378 .154 
9- Having difficulty 
concentrating on what is being 
said by the interlocutor 
.394 .636 .192 - .029 
10- Loosing things, or having 
difficulty finding them 
.386 .316 .456 .086 
11- Being distract from 
surround environment: noises 




12- Needing to get away from 
a situation in which one must 
be present. 
.536 .115 - .012 .325 
13- Feeling non-rested or 
agitated. 
.643 .223 .282 - .011 
14- Having difficulty to relax .666 - .003 .300 .040 
15- Talking too much in social 
situations. 
.085 .012 .027 .754 
16- Breaking-off a 
conversation when the other 
person has yet to finish 
talking. 
.122 - .002 .236 .694 
17- Difficulty to wait your turn .473 .339 - .243 .306 
18- Interrupt others when they 
are very busy 
.324 .316 - .227 .584 
Eingenvalue 2,8 2,8 2,6 1,9 






Table 8.  Demographic aspects in patient affected by Substance Use Disorder, with 
ADHD (ADHD) or without ADHD (noADHD) 
 
ADHD    noADHD 
N= 20    N= 89  f or hi2 p 
 
Age, mean (sd)     35,10 (7,66)    34,74 (8,46)   0,17    ns 
Gender, male, n (%)    16 (80,0)    65(73,0)  0,42    ns 
Civil status n (%) 
Unmarried      17 (85,0)    61(68,5) 
Married      1 (14,6)    13 (14,6) 
Separated o divorced    2 (10,0)    15 (16,9)  2,28    ns 
Work, n (%) 
Student      2 (10,0)    5 (5,6) 
Disoccupied      4 (20,0)    16 (18,0) 
Housewife      0 (0,0)      1 (1,1) 
Worker      11(55,0)    34 (38,2) 
Trader     0 (0,0)      7 (7,9) 
Employed     1 (5,0)    14 (15,7) 
Free lance      2(10,0)    11 (12,4) 
Pensioned      0 (0,0) 1    (1,1)   5,11    ns 
Education, n (%) 
University      1 (5,0)    2 (2,2) 
High school     3 (15,0)    33 (37,1) 





Table 9.  Diagnostic and clinical aspects  in patient affected by Substance Use 
Disorder, 
 with ADHD (ADHD) or without ADHD (noADHD) 
______________________________________________________________________ 
ADHD   noADHD 
N=20    N=89  t or hi2(df=1)  p 
Substance lifetime 
Alcol       8 (40.0)   31 (34.0)  1.25   ns 
Cocaine      7 (35.0)   34 (38.2)  .87   ns 
Heroine      10 (50.0)   58 (65.0)  .53   ns 
THC       2 (10.0)   24 (27.0)  .30   ns 
MDMA      2 (10.0)   10(11.2)  .88   ns 
Comorbidity lifetime. n (%) 
MDD       0 (0.0)   2 (2.2)  0.00   ns 
BD       16 (80.0)   38 (43.2)  8.84           .003 
Depressive Bip I     5 (25.0)   10 (11.2)  1.03   ns 
Mixed/Manic      8 (40.0)   15 (16.9)  3.29            .027 
Depressive Bip II     3 (15.0)   13 (14.6)  .01   ns 
Psiychotic symptoms 
Congruent      0 (0.0)   3 (3.4)  0.00   ns 
Incongruent      2 (10.0)   3 (3.4)  3.19   ns 
Rapyd Cycling     1 (5.0)   2 (2.2)  0.46   ns 
Panic Disorder     8 (40.0)   23 (25.0)  1.91   ns 
Social Phobia    1 (5.0)   2 (2.3)  2.29   ns 
DOC       2 (10.0)   0 (0.0)  7.90   ns 
Generalized Anxiety    0 (0.0)   2 (2.3)  0.00   ns 
Hympulsive Control Disorder   0 (0.0)   2 (2.3)  0.00   ns 
GAF. mean  (sd)     56.8 (13.9)   60.4 (17.8)  .99   ns 
Sheehan Disability Scale. mean (sd): 
Work       4.80 (2.78)   4.78 (2.14)  1.01   ns 
Family      4.35 (2.52)   4.56 (1.88)  .95   ns 
Social       4.20 (2.35)   4.64 (1.98)  .90   ns 
CGI-Bipolare Severity 
Manic       0.95 (1.43)   0.52 (0.91)  1.42           .097 
Depressive      2.10 (1.65)   1.46 (1.62)  1.26   ns 
Mixt       1.40 (2.01)   0.69 (1.42)  1.23          .071 
Anxiety     2.00 (1.69)   1.76 (1.75)  1.08   ns 
Himpulsivity      2.05 (1.93)   1.80 (1.84)  1.08   ns 






Table 10. Response to antidepressive treatment in patient affected by a Substance 
Use Disorder, with ADHD (ADHD) or without ADHD (noADHD). 
 
ADHD  noADHD 
N=20   N=89   t or c2(df=1) p 
 
Response to antidepressive treatment, n (%) 
 
Viraggio Ipomaniacale     2 (10.0)  7 (7.9)  .098   ns 
Instabilità Umore      6 (30.0)  13 (14.6)  2.69   ns 
Resistenza       3 (15.0)  3 (3.4)  4.25          .039 








Table 11. Factor analisys of ASRS items in 109 patients with Substance Use 
Disorder  
Item ASRS Factor 1  
Hyperactivity/ 
Hympulsivity 
Factor 2  
Inattention 
Factor 3  
Disorganizati
on 
1- Having difficulty in 
focusing and developing 
details of any a project. 
-.043 ,150 .722 
2- Having difficulty in 
arranging objects while 
performing a task that 
requires organization. 
.343 -.039 .692 
3- Having trouble 
remembering appointments 
and deadlines 
,451 -,033 ,290 
4- To avoid or delay the 
execution of a task that 
requires reasoning. 
,590 ,061 ,527 
5- Shaking hands or feet 
when the subject has to sit 
for a long time.  
.406 ,576 .079 
6- Feeling overly active or 
constraint to do something 
as if driven by a motor 
,067 ,429 ,473 
7- Making errors due to 
distraction while performing 
a difficult or tedious project. 
,722 ,181 ,005 
8- Having difficulty to 
sustain attention during a 
tedious or repetitive job. 
,682 ,336 -,336 
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9- Having difficulty 
concentrating on what is 
being said by the 
interlocutor 
,534   ,046 ,583 
10- Loosing things, or 
having difficulty finding 
them 
,715 -,002 ,061 
11- Being distract from 
surround environment: 
noises and activities 
,473 ,501 ,186 
12- Needing to get away 
from a situation in which 
one must be present. 
,484 ,277 ,159 
13- Feeling non-rested or 
agitated. 
,043 .287 ,514 
14- Having difficulty to relax ,052 ,331 ,466 
15- Talking too much in 
social situations. 
,097 ,695 ,061 
16- Breaking-off a 
conversation when the 
other person has yet to 
finish talking. 
-,129 ,771 ,118 
17- Difficulty to wait your 
turn 
,170 ,415 ,244 
18- Interrupt others when 
they are very busy 
,283 ,570 ,171 
Eingenvalue 3,2 2,8 2,6 






Table 12. Demographic aspects in patient with Sustance Use Disorder (SUD), 
Bipolar Disorder (BD), and dual diagnosis (SUD+BD)  
 
 SUD  BD SUD+BD 
 N= 53 N=50 N=44 f or 2 p 
 
Age, mean (sd) 24.8 (9.6) 42.9 (15) 34.9 (6.8) 8.6<.0001 
Gender, male, n (%) 38 (71.7) 23 (46) 34 (77.3) 11.8 .003 
Civil status, n (%) 
Unmarried 34 (64.2) 21 (42) 35 (79.5) 
Married 9 (17) 24 (48) 4 (9.1) 
Separated/divorced 10 (18.9) 5 (10) 5 (11.4) 23.5 .0001 
Work, n (%) 
  Student 7 (13.21) 8 (16) 5 (11.36) 
  Disoccupied                    12 (22.64) 14 (28) 10 (22.73) 
  Worker 23 (43.4) 18 (36) 22 (50) 
  Employed 11 (20.75) 10 (20) 7 (15.91) 2.2 ns 
Education, n (%) 
  University 1 (1.9) 7 (14) 1 (2.3)  
  High school 20 (37.7) 19 (38) 11 (25)         







Figure 1. ADHD diagnosis in patient with Sustance Use Disorder (SUD), Bipolar 
Disorder (BD), and dual diagnosis (SUD+BD)  























Table 13. Diagnostic and clinical aspects in patient with Sustance Use Disorder 
(SUD), Bipolar Disorder (BD), and dual diagnosis (SUD+BD)  
 SUD  BD SUD+BD 
 N= 53 N=50 N=44 f or 2(df) p 
Psychiatric Disorder, n (%): 
BD. I (MDD)                 -- 8 (16) 12 (27.3) 1.8(2) ns 
BD I (Mixed states)         --  12 (24) 18 (40.9) 3.8(2) .08 
BD I (Mania)                 -- 9 (18) 0 (0.0) 8.8(2).003 
BD II (MDD)                -- 12 (24) 13 (29.5) 0.4(2) ns 
BD in remission             -- 9 (18) 1 (2.3) 6.1(2) .01 
Psychotic congruent             -- 3 (6) 1 (2.3) 0.8(2) ns 
Psychotic incongruent 2 (3.8) 5 (10) 3 (6.8) 1.0(3) ns 
Substance, n(%): 
Alcol 17 (32.1)           -- 7 (15.9) 3.4(2) .07 
THC 7 (13.2)           -- 4 (9.1) 0.4(2) ns 
Cocaine and stimulants 13 (24.5)           -- 17 (38.6) 2.2(2) ns 
Heroine 16 (30.2)           -- 16 (36.4) 0.4(2) ns 
 
Comorbidity Lifetime, n (%) 
Major Depressive Disorder  2 (3.8)             --                     -- 
Panic Disorder 5 (9.4) 3 (6.0) 7 (15.9)  2.6(3) ns 
PD-Agoraphobia 2 (3.8) 7 (14.0) 5 (11.4) 3.4(3) ns 
GAD 1 (1.9) 5 (10.0) 1 (2.3) 4.6(3) ns 
Social Phobia 1 (1.9) 1 (2.0) 1 (2.3) 0.2(3) ns 
DOC 0 (0.0) 2 (4.0) 1 (2.3) 0.8(3) ns 
Alcol 3 (5.7) 4 (8.0) 9 (20.5) 6.1(3) .05  
Heroine 1 (1.9) 1 (2.0) 1 (2.3) 0.2(3)  ns 
Cocaine and Stimulants 4 (7.8) 1 (2.0) 9 (20.5) 6.0(3) .05 
Poliabuse 7 (13.2) 0 (0.0) 18 (40.9) 9.6(3).002 
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GAF, mean (sd) 61.8 (20) 52.4 (22.4) 55.7 (12.2) 3.3 .04 
Sheehan Disability Scale, media(sd): 
Work 4.6 (2.3) 4.4 (2.3) 5.2 (2.1) 1.4 ns 
Family 4.4 (2.1) 3.8 (2.0) 4.6 (1.9) 2.1 ns 
Social 4.4 (2.1) 4.5 (2.1) 5 (29) 1.1 ns 
CGI-Bipolare, severity: 
Manic 0.3 (0.7) 1.9 (1.8) 0.5 (1.0) 23.8<.0001 
Depressive 0.9 (1.3) 2.4 (1.6) 2.2 (1.8) 13.4<.0001 
Mixed 0.2 (0.8) 1.2 (1.7) 1.1 (1.9) 5.7 .004 
Anxiety 1.8 (1.7) 1.9 (1.7) 1.5 (1.8) 0.4 ns 
Hympulsity 1.7 /(1.8) 0.9 (1.4) 1.9 (2.1) 4.3 .01 





Table 14. ASRS scores comparison in patient with Sustance Use Disorder (SUD), 
Bipolar Disorder (BD), and dual diagnosis (SUD+BD)  
 SUD  BD SUD+BD 
 N= 53 N=50 N=44 F p 
Items, mean (sd): 
1- Having difficulty in focusing  
and developing details of any a project. 
  0.9 (0.9) 1.2 (1.1) 1.3 (1) 1.9 ns 
2- Having difficulty in arranging  
objects while performing a task that requires organization. 
 1 (1.1) 1.2 (1.2) 1.6 (1.3) 3 0.05a 
3- Having trouble remembering  
appointments and deadlines 
 1.4 (1.2) 1.3 (1.3) 1.7 (1.3) 1.2 ns 
4- To avoid or delay the execution  
of a task that requires reasoning. 
 1.5 (1.1) 1.5 (1.2) 1.9 (1.3) 2.1 ns 
5- Shaking hands or feet when the subject  
has to sit for a long time. 
 1.6 (1.3) 1.5 (1.3) 1.7 (1.3) 0.4 ns 
6- Feeling overly active or constraint  
to do something as if driven by a motor 
 1.3 (1.3) 1.3 (1.3) 1.4 (1.4) 0.6 ns 
7- Making errors due to distraction while  
performing a difficult or tedious project. 
 1.6 (0.9) 1.6 (1) 1.7 (0.9) 0.5 ns 
8- Having difficulty to sustain attention  
during a tedious or repetitive job 
 1.7 (0.9) 1.8 (1.1) 1.7 (1.2) 0.2 ns 
9- Having difficulty concentrating on what is  
being said by the interlocutor 
 1.4 (1) 1.3 (1.1) 1.5 (1.2) 0.5 ns 
10-- Loosing things, or having  
182 
 
difficulty finding them 
 1.5 (1.1) 1.6 (1.1) 1.5 (1.4) 0.2 ns 
11- Being distract from surround  
environment: noises and activities 
 1.7 (0.9) 1.6 (1) 1.8 (1.2) 0.5 ns 
12- Needing to get away from a situation 
 in which one must be present. 
 1 (1) 1 (1.2) 1.3 (1.2) 1.2 ns 
13- Feeling non-rested or agitated. 
 1.9 (1) 2.2 (1) 2.2 (1) 1.7 ns 
14- Having difficulty to relax 
 1.3 (1.2) 1.7 (1.2) 2.1 (1.3) 5.0 .008b 
15- Talking too much in social situations. 
 1.4 (1) 1.7 (1.4) 1.5 (1.3) 0.5 ns 
16- Breaking-off a conversation when the  
other person has yet to finish talking. 
 1.7 (1) 1.7 (1.1) 1.6 (1.2) 0.1 ns 
17-- Difficulty to wait your turn 
 1.2 (1.2) 1 (1.1) 1.6 (1.1) 3.5 .03 
18- Interrupt others when they are very busy 
 1.1 (0.9) 0.9 (1) 1.2 (1.1) 1.3 ns 
Total Scores (first 6 Items) 
 7.9 (3.8) 7.9 (4.1) 9.6 (5.3) 3.7 .05a 
Total Scores (18 Items) 25.3 (9.0) 25.9 (9.5) 29.4 (13.2) 3.8 .05a 
 
Bonferroni Analysis Post Hoc: aSUD+BD>BD,SUD; bSUD+BD>SUD 
 
 
